






















Background:     
Single cell transcriptome studies have recently advanced to the analysis of millions of cells in 
a single pipeline. This type of analysis requires expensive, high maintenance platforms, 
precluding its use in most laboratories. Therefore, there is a need to find innovative ways of 
using more accessible low throughput methods for clinical application. Understanding the 
gene expression of an individual cell has clinical applications ranging from improved 
diagnosis to more precise treatment. We developed a novel single cell transcriptome 
analysis method and adapted it for ultra-low input mRNA analysis to potentially improve 
cancer diagnosis. 
 
Methods:     
Our single cell transcriptome analysis method allowed us to determine if the detection of 
single prostatic cells in various backgrounds could identify novel quantitative PCR 
biomarkers that could be used in urine diagnosis of prostate cancer. We applied this 
method to detect single cells from the LNCaP and PC3 prostate cancer cell lines in 
populations of prostatic (LNCaP) and non- prostatic (HeLa) cells. We used up to 29 cells from 
the HeLa cell line as a non-prostatic background for detection of a single LNCaP and PC3 
cells. We also used up to approximately 199 LNCaP cells as a prostatic background to detect 
a single PC3 cell.  
 
Results: 
Our method detected 23 gene isoforms that significantly distinguish (P < 0.05) a single PC3 
cell from a background population of approximately 199 LNCaP cells. 161 gene isoforms 
significantly distinguished (P < 0.05) a single PC3 cell from a background population of 29 
HeLa cells. 64 gene isoforms significantly distinguished (P < 0.05) a single LNCaP cell from a 
background population of 29 HeLa cells. The MAGED1 gene had the highest log fold change 
in PC3 cells compared to HeLa cells (log2 fold change = 9.3, P < 0.05) and significantly 
distinguished (P < 0.05) a single PC3 cell from a background of 29 HeLa cells. qPCR analysis 
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Transcriptome wide single cell analysis identified several genes that indicate the presence of 
single PC3 and LNCaP cells in background populations of cells. This result supports a single 
cell sampling approach to highly sensitive diagnostics and prognostics for ultra-low input 
RNA samples. Our single cell analysis method compares positively with methods described 
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Understanding the relationship between genotype and phenotype is the principle aim of 
biological science. A key tool to assist this understanding is the study of transcriptomes. The 
100 trillion cells in a typical human adult may share nearly identical genotypes, however 
transcriptome information reflects a unique subset of active genotype in each cell at a given 
time. Furthermore, due to the diverse array of cells that make up an organism, organ or 
tissue, bulk analysis of tissues omits biological differences between individual cells (Figure 
1.1). These individual cell differences may have organism level consequences. Single cell 






Single cell transcriptome analysis has advanced from the study of a handful of cells to high 
through put analysis of millions of cells in a single analytical pipeline (Svensson et al., 2018). 
This advancement in technology has taken place in the last 5 years, generating terabytes of 
data in a relatively short period of time (Figure 1.2). In 2016, the Human Cell Atlas 
Consortium emerged from these advances to discover, map and describe all human cell 
types. This represents the latest in a long line of consortia punctuating each major 
advancement in biology, beginning with the Human Genome Project. Science magazine 
Figure 1.1 – Single cell vs. bulk cell analysis 




hailed high throughput single cell RNA-seq as the 2018 “Breakthrough of the year” for its 








The effort to identify rare cell types has emphasised the importance of maximising the 
number of single cell transcriptomes analysed. Identifying rare cell types has significant 
implications for immunology and oncology, where rare cell types can have significant 
consequences for patient outcomes. Tumours and the immune system are complex 
ecosystems due to their high connectivity, heterogeneity and plasticity. External cell 
markers have proven inadequate in delineating cell types in these systems (Hume et al., 
2008; Lawson et al., 2018). Therefore, high-through put single cell transcriptome analysis is 
the only effective tool for comprehensive cellular segregation of complex tissues without 
the need for predefined markers (Giladi and Amit, 2018). 
 
In the drive to improve cell number through put, single cell transcriptome analysis has 
transitioned away from laboriously depositing single cells in plated wells, to using 
microfluidic cell technology to separate cells and complete the amplification reaction in a 
dynamic process. Currently, the most common single cell transcriptome library preparation 
Figure 1.2 – Development of single cell transcriptome analysis 
The first major jump in single cell processing volume was achieved through multiplexing by Islam et al. 
(2011), with STRT-seq. Fluidigm C1 was the earliest commercial microfluidic tool to isolate single cells and 
combined the SMART-seq reaction protocol to prepare multiplexed libraries for Next Generation Sequencing 
(NGS) analysis. Subsequent microfluidic tools, such as inDrop and Drop-seq, used nano-litre droplets to 
isolate single cell reactions. The 10X Genomics platforms are the latest iteration of oil droplet microfluidics 
(Svensson et al., 2018). 
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method is high through-put microfluidic technology (Kulkarni et al., 2019). The three most 
widely used platforms are 10X Genomics Chromium, Drop-Seq and inDrop. These 
approaches use microfluidics to tag individual droplets containing an individual cell with a 
unique barcode. Within each cell, unique molecular identifiers also tag each mRNA 
transcript, allowing for the removal of technical biases.  
 
Consequently, low-throughput methods have been over-shadowed by high-throughput 
methods. The remaining advantages of low-throughput well based methods is that they use 
ubiquitous skills, equipment and limited infrastructure. Any laboratory with RNA-seq 
analysis capabilities may use these methods without a significant capital investment. The 
essential components include 96 well plates, reagents for mRNA amplification and a method 
for isolating single cells and RNA-seq technology. Recasting low-throughput single cell 
technologies for studying ultra-low input mRNA could lead to their re-establishment, 
particularly in the context of poorly resourced research environments. 
 
In 2015, Day et al. (2018) developed a well-based single cell transcriptome method that is 
scalable to potentially hundreds of cells in a single analytical pipeline. We applied a part of 
the Day et al. method herein to analyse ultra-low input RNA samples and single cell 
transcriptomes. The method is comparable to SMART-seq2 because it is well-based and 
involves a PCR amplification to create a cDNA library amenable to RNA-seq analysis (Picelli 
et al., 2014)). In terms of raw numbers of cells analysed, this technology cannot compete 
with current high-throughput droplet based microfluidic technologies.  
 
Day et al.’s method has the advantage over SMART-seq2 with regards to early multiplexing 
of single cell samples, where each well in a 96-well plate is assigned a 5’ barcode before 
library amplification. Although this method is relatively low throughput, we demonstrate 
that it remains a useful tool for cheaply interrogating single cells and micro-populations of 
cells to answer contemporary biological questions. One of the novel questions this thesis 
aims to address is the ability of a single cell RNA-seq method to analyse a population of cells 
and detect a single cell transcriptome of interest in that population. This application of a 
single cell technology to micro-population analysis could encourage re-adaption of low 
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throughput single cell technologies to novel contexts outside of analysing individual single 
cells. 
 
Given the potential of our method to analyse multiplexed micro-populations of cells, this 
allows our method to process cells in the order of thousands in one pipeline. This may be of 
clinical relevance to urine samples, where a patient may shed upwards of 6000 intact cells 
within a 24-hour period (Lang et al., 2013). For example, very early stage prostate cancers 
may shed very small numbers of cancer cells in urine, particularly after intensive prostate 
massage (Mengual et al., 2016). Distributing urinated cells across 96 well plates could allow 
a sensitive single cell method to detect a single shed cancerous or pre-cancerous cell 
amongst small sub-populations of cells in each well.  
 
There are presently diagnostic tools available to detect cell free mRNA transcript disease 
biomarkers in urine. However, combining a sensitive single cell transcriptome method that 
can detect low abundance transcripts with well plate based segregating of micro-
populations of urinated shed cells may offer advantages. Such a method could detect 
significantly more de novo mRNA species with diagnostic significance than using a pre-
defined suite of qPCR targets. Ultra-low input mRNA that can be analysed directly after cell 
lysis means that the risk of RNA degradation is lowered. mRNA integrity can be maintained 
for hours when it is protected by cellular membranes (Meng et al., 2012; Fujita et al., 2009; 
Quek et al., 2012). 
 
We developed an experimental design to test the hypothesis that a single cell method can 
be used to interrogate small populations of cells to identify a single cell transcriptome of 
interest. We used the PC3 and LNCaP prostate cancer cell lines as a model of uro-genital 
disease. We compared our single cell data with analogous data from SMART-seq2, another 
well based method used as standard practice in many laboratories (Baran-Gale et al., 2018) 
These cell lines were also used for model single cells in the paper describing SMART-seq2 





The first chapter of this thesis is a survey of the latest developments in single cell 
transcriptome analysis methodology, including computational analysis and current 
challenges in the field. We briefly outline the thesis objectives, our single cell transcriptome 
analysis methodology and experimental design. We discuss the thesis method in the 
modern context. The final section describes the modern computational analysis methods 
and our own computational approach for analysis of our single cell transcriptome data. 
 
The second chapter is a detailed description of the thesis single cell transcriptome 
methodology and experimental design. The computational analysis and normalisation 
method of the experimental data is also outlined. Finally, qPCR experiments ancillary to our 
initial findings are described. 
 
The third chapter is a presentation of the RNA-seq data generated by our single cell 
transcriptome platform and a comparison with analogous data from Picelli et al. (2008) 
generated by a different methodology. The data described originated from single PC3 and 
LNCaP cells. We present qPCR validation of the RNA-seq data generated by our method. We 
also describe data from the application of our platform to detecting the transcriptome of 
single cells in a dissimilar cell population.  
 
The final chapter is a discussion of our data in the current context of single cell technology 
literature. We critically evaluate the advantages and disadvantages of our method and 
experimental design. We also review the challenges in computational analysis. Finally, 
future directions of the single cell transcriptome field are discussed. 
 
1.2 Single cell transcriptome sequencing methods 
Although single cell RNA-seq technologies have advanced profoundly in terms of through 
put, they still retain the basic features of all single cell analysis methods. There are three 
broad steps in common between microfluidic and well based approaches:  
i. Isolating the cells of interest from a background of uninteresting cells;  
ii. Reverse transcription of mRNA to double stranded cDNA; and  
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iii. Amplification of the cDNA to levels amenable to analysis, whether by qPCR (end-
point analysis) or further whole transcriptome sequencing. 
Microfluidic technologies such as the single cell controller platform from 10X Genomics 
encapsulate single cells into nanolitre droplets containing DNA barcoded reads for reverse 
transcription. After reverse transcription, the cDNA for each single cell is uniquely DNA 
barcoded and can multiplexed in a single RNA-seq run. These high through-put technologies 
can channel millions of individual cells through a microfluidic chip with compartments that 
isolate cells for the reverse transcription and amplification reaction.  
 
Well based technologies such as SMART-seq2 can take advantage of micro-pipetting or 
fluorescence-activated cell sorting (FACS) to isolate single cells from tissues. Micro-pipetting 
is a non-biased and straightforward for cell culture after trypsinisation, which was the 
method for isolating single cell in this thesis. FACS can introduce biological bias from 
transcriptomes being linked to the cell surface protein markers, cell size and cell cycle 
status. Single cells can then be deposited into 96 or 384 well plates containing a cell lysis 
buffer and excess ribonuclease inhibitor to protect the RNA. This type of cell isolation 
requires the cells to be processed quickly with all downstream work carried out on ice. 
 
Both the microfluidic Genome 10X approach and the well plate based methods enrich for 
coding mRNA by using an oligot(dT) containing primers for RT and PCR. This is possible 
because oligo(dT) anchors to the poly adenine (poly A) tail of mature mRNA, but may also 
anchor to internal poly A regions of mRNA transcripts. 
1.2.1 Droplet microfluidic technologies 
Single cell microfluidics is primarily a method of isolating large numbers of individual cells 
for transcriptome analysis. Fundamentally, it involves isolating single cells inside oil droplets 
through microfluidic channels. In the case of Genome 10X platforms, this allows a 
compartmentalised reaction to attach a unique gel bead barcode for each single cell 
transcriptome (Figure 1.3). This process forms gel beads in emulsions (GEMs), where 
barcoded individual transcriptomes can be pooled for more efficient downstream reactions.  
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The Genome 10X single cell platforms have been the most prolifically utilised microfluidic 
tools in recent years. Over 1200 instruments have been sold to 93 out of 100 of the top 
research institutions by publications, generating over 500 publications since the single cell 
series was released in mid 2015. The defining advantage of the 10X system is its ability to 
process many cells in a short space of time. It can capture 100-10,000+ cells per output 
channel and up to 80,000 cells per run in < 7 minutes. Although popular, wilful intellectual 
property violations have resulted in court injunctions preventing further sale of this system. 
This has resulted in Genome 10X releasing a new platform in late 2019 with a similar cell 
processing capability. 
 
The purpose of the Genome 10X single cell system is to create an emulsion of oil droplets, 
each containing a single cell (Figure 1.3). mRNA in each droplet is reverse transcribed to 
cDNA containing a unique molecular barcode attached to a gel bead. The barcode allows for 
downstream pooling of samples and bulk amplification by PCR followed by bulk NGS. The 
emulsion is created by a chip containing eight units of wells and channels. Each unit 
comprises three wells feeding a network of channels leading to an outlet well for the 
emulsion. Each set of wells includes: (i) a sample well containing disassociated cells and 
reagents for reverse transcription; (ii) a well containing the droplet forming oil; and (iii) a 
well containing the barcoded beads.  
 
The contents of the input wells combine in the channel network to release a functional GEM 
containing a single cell, a single gel bead, and RT reagents. Within each GEM reaction 
vesicle, a single cell is lysed, the gel bead is dissolved to free the identically barcoded RT 
oligonucleotides into solution. Reverse transcription of mRNA subsequently occurs, 
resulting in all cDNAs from a single cell attached to the same barcode. This allows 
sequencing reads to be indexed to their original single cells.  
 
While the 10X single cell system has significant advantages in terms of high volume single 
cell analysis, it has some drawbacks (Luo et al., 2019). Single cells and gel beads are 
randomly encapsulated in each droplet and the number droplets containing cells follows a 
non-uniform poisson distribution. This means very few droplets will contain both a 
barcoded bead and a single cell. Cell capture rates vary from 50-65%, making it more 
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difficult to capture rare cell types. In addition, some cell types adhere very tightly together, 
resulting in some GEMs containing multiple cells. complicating computational single cell 
analysis. These ‘mulitplets’ are likely to add significant noise to single cell computational 
analysis. Cells derived from trypsinised cell culture or liquid biopsies are more likely to 







Figure 1.3 – Genome 10X single cell system 
The eight channel microfluidics chip permits the isolation of a large number of single cells by oil 
droplets formed around a cell, reagents and a barcoded primer gel bead. The RT reaction takes place 
inside each droplet to incorporate the 10X barcode for downstream aggregation of cells for an efficient 




SMART-seq2 is the commercial standard plate based method for single cell analysis 
currently offered by Illumina (Picelli et al., 2014). Both SMART-seq2 and the Genome 10X 
method exploit the SMART reaction (Switching Mechanism at the end of the 5’-end of the 
RNA transcript). This template switch mechanism enables the incorporation of forward and 
reverse PCR primers following reverse transcription of the mRNA.  
 
Developed by Matz et al. (1999), the template switch procedure utilises the ability of the 
Moloney Murine Leukemia Virus (MMLV) reverse transcriptase to add a few non-templated 
cytosines to the 3’ end of the newly synthesized cDNA strand (Figure 1.4). This usually 
occurs when the reverse transcriptase reaches the capped 5’ end of the mRNA. These extra 
cytosines work as a docking site for the three riboguanosines attached to a ‘Template 
Switching Oligonucleotide’ (TSO). The reverse transcriptase is then able to ‘switch template’ 
(from mRNA to the DNA of the TSO) and synthesize a complementary DNA strand using the 
TSO as template (Picelli, 2017).  
 
SMART-seq2 is the second generation of this method, developed in in 2013 by Picelli et al. 
The TSO in the Smart-seq2 method replaces the terminal riboguanosine with a locked 
nucleic acid (LNA)-modified de-oxyguanosine (Figure 1.4). Locked nucleotides are 
characterized by an internal bond between the O2ʹ and the C4ʹ of the furanose ring, linked 
by a methylene group (Picelli, 2017). The modification introduces a conformational 
restriction in the molecule, which still retains the physical properties of the original nucleic 
acid. Two properties of LNAs are advantageous for template switching: the enhanced 
thermal stability of the LNA monomers and their ability to anneal strongly to the 
untemplated 3ʹ extension of the cDNA. 
 
SMART-seq2 also improved the lower read coverage towards the 5’ end of transcripts that 
was characteristic of full length coverage methods up to that point. The addition of MgCl2 
and betaine to the template switch reaction assisted in processivity of the DNA polymerase 
(Picelli et al., 2013) The final and perhaps most important advantage of SMART-seq2 is that 
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it entirely relies on off-the-shelf reagents, reducing the capital investment required 
compared to microfluidic methods. 
 
SMART-seq2 has some important limitations depending on the biological hypothesis to be 
tested. Samples can only be pooled immediately prior to sequencing, making the method 
more labour intensive than barcode tag-based methods such as STRT-seq (Islam et al., 
2014). Despite being a well based approach with lower cell through-put, SMART-seq2 has 
important advantages compared to Genome 10X microfluidic technologies. Smart-seq2 is 
able to detect more genes per cell than Genome 10X, making it a more appropriate tool for 
experiments requiring high sensitivity (Wang et al., 2019).  
 
Well based methods such as SMART-seq2 have attributes that continue to make them 
relevant to current biological questions related to ultra-low RNA inputs. A modified SMART-
seq2 method was recently used to investigate endogenous retroviral differential gene 
expression between low numbers of immature and mature mouse oocytes (Treger et al., 
2019). This approach enabled sensitive detection of low-abundance retro-element 
transcripts in growing oocytes and to detect differential expression between sub-strains. 
The full-length read coverage of SMART-seq2 also enabled improved mapping accuracy of 
repeat elements compared to a 3’ tag sequencing method used by Genome 10X (Treangen 
and Salzberg, 2011). The low cost of SMART-seq2 was also noted in the study. 
 
Unlike Genome 10X, SMART-seq2 analyses the full length of the mRNA transcript by using a 
tagmentation reaction. This precludes the use of unique molecular identifiers (UMIs) for 
molecular counting. Molecular counting enables the calculation of the absolute numbers of 
each original mRNA transcript. Islam et al. (2014) determined the absolute quantity of 
original mRNA transcripts by tagging each mRNA molecule with a UMI (a random 5bp 
sequence) before amplification. The quantity of original molecules for each mRNA species 
should therefore correspond to the quantity of unique molecular identifiers present in the 
amplified population for each mRNA species.  
 
The tagmentation reaction that introduces sequencing primers to transcripts for next 
generation sequencing converts full cDNA strands into multiple fragments (Figure 1.4). 
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Therefore, the UMI barcode would be lost because it can only label the terminal portion of 
the full-length transcript. Molecular counting of fragmented transcripts is still possible with 













Figure 1.4 – Smart-seq2 protocol 
Outline of the SMART-seq2 protocol and the corresponding procedure steps (Picelli et al., 2014). Poly A 
mRNA is reverse transcribed from an oligo(dT) primer. The MMLV derived reverse transcriptase adds 2-
5 cytosines to the newly synthesised cDNA (3 in figure). The LNA-containing TSO carries 2 
riboguanosines (rG) and a LNA modified guanosine (+G). Both the oligo(dT) and LNA-containing TSO 
contain palindromic PCR primers (ISPCR primers) to enable PCR amplification of the cDNA. The 
amplified cDNA is then prepared for sequencing by tagmentation via Tn5 transposase. The cDNA is 
fragmented and another set of PCR primers are attached to each fragment for further PCR, followed by 





The overall aim of this thesis was to troubleshoot and test a novel well based single cell 
transcriptome method, and subsequently apply it to analysis of a bulk cell micro-population 
context to determine if the method could delineate a single cell in a bulk sample. In testing 
the single cell method, we used the method to analyse the single cell transcriptomes of two 
prostate cancer cell lines and compare the data generated to SMART-seq2 data generated 
from the same cell lines. This comparison enabled us to have a point of reference for 
evaluating both methods. 
 
After establishing a method capable of analysing whole mRNA from single cells and ultra-
low inputs, we created an experimental design to detect a single cell in a bulk sample. The 
purpose of this aim was to see if the method could be applied to detect a large number of 
mRNA species from a single cell of interest in micro-population samples, with a view 
towards future diagnostic applications in a cancer fluid biopsy context. To this end, we 
created various combinations of two prostate cancer cell lines and the HeLa cell line with a 
single cell deposited in a background.  
 
The biological question which we want to address is the sole determinant of the 
appropriateness of the technique we wish to use, irrespective of advancements in through-
put. We suggest that a well plate based technique is more appropriate than a microfluidic 
technique high through put technique because it remains capable of answering the specific 
biological question we wish to address and is much more accessible in terms of cost. 
 
1.4 Thesis method and design 
This thesis utilised part of an innovative well plate based method described by Day et al. 
(2018) that can be used for single cell transcriptome and ultra-low input RNA analysis. The 
method was coupled with an experimental design to analyse ultra-low input mRNA derived 
from a micro-population of cells to detect a single cell transcriptome amongst a population. 
The method adapts features from other plate based single cell analysis methods. Day et al. 
(2018) incorporate elements such as template switching, PCR amplification and 
tagmentation from SMART-seq2 and barcoding of individual cells by the oligo(dT) from 
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STRT-seq (Picelli et al., 2014; Islam et al., 2011). This early barcoding enables downstream 
pooling of samples post RT to reduce the costs and labour of sample amplification.  
 
The Day et al. method also incorporates an in vitro transcription (IVT) step. IVT was first 
described by Eberwine et al. (1992) as a method to linearly amplify cDNA derived from 
single cells. We utilise IVT post PCR to focus our analysis on the 3’ end of mRNA transcripts, 
eliminating the need for gene length correction for data normalisation. Linear amplification 
methods for single cells have been largely based on the T7 RNA polymerase (T7), derived 
from bacteriophage. The T7 catalyses the formation of first strand anti-sense RNA (aRNA) 
from template cDNA (known as in vitro transcription or IVT). T7 can amplify RNA up to 1000 
fold in one round of amplification (Wilhelm et al., 2006). It has the advantage of being 
extremely specific to a T7 promoter sequence. Limitations include the low processivity of T7 
and a requirement for double stranded promoter sequence to initiate T7.  
 
The inherent limitation of single cell IVT is that at least 400pg of starting RNA is required. 
Hashimshony et al. (2012) remove this problem by pooling samples that have been 
barcoded with a unique sequence in the Oligo-dT after the reverse transcription while also 
providing a multiplex capability similar to the PCR STRT method. We similarly overcome this 
hurdle by pooling samples post PCR into a single aliquot for IVT amplification. Hashimshony 
et al. (2012) compared the data gathered from their method with the data from Islam’s PCR 
method, and found their linear method was more reproducible, amplified more genes than 
STRT, and was better able to distinguish gene expression levels between different cell types. 
1.4.1 Experimental design 
We designed three experiments in order to address the aim of detecting mRNA transcripts 
from a single cell in a micro-population. We deposited either a single PC3 or LNCaP cell in 
background populations of either approximately 29 HeLa cells or 199 LNCaP cells. As 
illustrated in Chapter 2, we compared the samples with a deposited single cell with sample 
composed of entirely of the background population with a similar number of cells to carry 
out differential gene expression analysis with an empirical Bayes method. 
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1.5 Prostate cancer cell lines 
Prostate cancer is the most common cancer in men and has significant challenges in 
diagnostic and prognostic accuracy (Catalona et al., 2017). The development of more 
specific biomarkers for high-risk prostate cancer is necessary, because the prostate-specific 
antigen (PSA) blood test lacks specificity for the detection of prostate cancer and can lead to 
unnecessary prostate biopsies (Siegel et al., 2013; Ferlay et al., 2010).  
 
There is scope for ameliorating diagnostic specificity and sensitivity through improving 
analysis of cellular components of prostate cancer sloughed into urine. A great 
improvement in high-throughput gene expression techniques has yielded several promising 
molecular biomarkers for prostate cancer detection (Mengual et al., 2016). This has 
potential for improving multiplexed qPCR assays for urinary RNA. Testing our experimental 
design on different prostate cancer cell lines is a logical initial step with a view towards 
analysing micro-population samples in patient urine. 
 
The cell types we used were determined by both the potential future clinical applications, 
availability, and what cell lines had been studied in the literature. We applied our method 
and experimental design to the PC3 and LNCaP prostate cancer cell lines. These two cell 
lines broadly model the two major types of prostate cancer in terms of aggressiveness and 
cell differentiation. They have been used in previous single cell transcriptome studies (Picelli 
et al., 2014). 
 
Prostate cancer can be roughly divided into two subtypes: androgen dependent (AD) and 
androgen independent (AI). Early stage prostate cancers tend to be AD. AD prostate cancers 
require androgen receptor signaling activated by testosterone derivatives for growth 
(Karantanos et al., 2013).  
 
Chemical castration reduces the amount of testosterone in the blood, resulting in shrinkage 
of AD prostate tumours. This effect is usually temporary, with AI prostate cancer emerging 
after a mean time of 2-3 years. The reasons for this are largely unknown, but recent 
investigations support the theory that androgen removal provides a selective advantage to 
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AI cells, which eventually repopulate the tumour (Taplin et al., 1999; Craft et al., 1999; Culig 
et al., 1998; Li et al., 2001).  
 
AI prostate cancer can be caused by mutations to the androgen receptor that increase 
sensitivity to the few testosterone derivatives remaining or mutations that broaden the 
specificity of AR, so that it can be activated by non-androgenic molecules. PSMA (FOLH1) 
gene expression has been implicated as providing an alternative mechanism to androgen 
driven growth by increasing folic acid levels, an important molecule for rapidly dividing cells 
(Yao et al., 2010).  
 
The LNCaP cell line is an AD cell line that requires the androgen present in foetal bovine 
serum cell culture medium for growth. LNCaP was established from a metastatic lesion of 
prostate adenocarcinoma from a 50-year-old Caucasian male (Chu et al., 1983). LNCaP  
tends to express androgen regulated genes such as PCA3 and PSA (Ferreira et al., 2012).  
 
PC3 is an androgen insensitive cell line and is therefore lacking in PSA and PCA3 expression. 
PC3 was established from a bone metastasis of Grade IV metastatic prostate 
adenocarcinoma from a 62 year old Caucasian male (Kaighn et al., 1979). PC3 is not 
considered clinically relevant because it forms osteolytic lesions in vivo, whereas clinical 
prostate cancer bone metastasis is osteoblastic. LNCaP tends to express PCA3 and PSA, 
whereas PC3 does not.  
 
1.5 Computational analysis 
A significant part of this thesis was devoted to computational analysis of the data generated 
by the single cell and micro-population experiments. There are significant computational 
challenges in single cell analysis related to data normalisation and cell type identification. 
Several computational pipelines exist for single cell analysis, but gold standard tools have 
yet to be developed (Hwang et al., 2018). 
 
One of the major challenges in single cell RNA-seq analysis is data normalisation. The 
purpose of data normalisation is to remove the effects of systematic technical variability 
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and unwanted biological variability in gene expression, so that biological differences of 
interest can be observed. Several normalisation techniques for single cell RNA-seq have 
been proposed, including scaling methods (Lun et al.,2016), regression based methods for 
known nuisance factors (Buettner et al., 2015) and methods that rely on spike-in sequences 
from the External RNA Controls Consortium (ERCC). 
 
We describe a data normalisation protocol in Chapter 2 and discuss the relevant literature 
with regards to our method in Chapter 4. We aimed to remove variation between single 
cells attributable to technical biases and identify any significant bias due to the cell growth 
cycle. In Chapter 2 we also illustrate how our experimental design uses computational 
analysis of differential gene expression between a study population and a homogenous 
control population to identify several mRNA transcripts from a ‘rare’ single cell in a 
population background. We utilised an empirical Bayes approach for differential gene 
expression analysis. 
 
Apart from data normalisation, we considered issues related to using clustering algorithms 
to identify single cell types. To this end, we primarily reduced the thousands of dimensions 
involved in a transcriptome to the first two principal components. This was used in 
conjunction with partitioning around the medoids (PAM) clustering to distinguish single cell 
types. Principal components analysis (PCA) is a common linear method for simplifying single 
cell datasets. In contrast to non-linear methods such as t-SNE, linear methods tend to 
preserve global data structure and are better at separating clusters (Nguyen et al., 2019). 
 
In Chapter 4 we discuss how the attributes of an empirical Bayes framework are useful for 
single cell analysis in the context of mitigating outlier effects, technical bias and possibly 
biological bias stemming from the cell cycle effect. An empirical Bayesian approach to single 
cell data normalisation was recently described by Tang et al. (2019). Empirical Bayes makes 
use of global scaling factors that corrects technical variations including differences in 
capture efficiency (Catalina et al., 2017). Also, global scaling factors correct for biological 
variations due to difference in transcript content and cell size. 
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Chapter 2 
2. Materials and Methods 
2.1 Materials 
2.1.1 Reagents 
0.05% trypsin solution (prepared in lab, Appendix 5.8.2) 
Ambion™ MessageAmp™ II aRNA amplification kit (Thermo Fisher Scientific, USA) 
AMPure® XP magnetic beads (Thermo Fisher Scientific, USA) 
Betaine, 5 M (Sigma-Aldrich, USA) 
Dimethyl sulfoxide (DMSO – Sigma-Aldrich, USA) 
dNTP Mix, 10mM (Invitrogen, USA) 
Dulbecco's phosphate-buffered saline (DPBS – Sigma-Aldrich, USA) 
Dulbecco’s modified Eagle’s medium and F12 medium (DMEM-F12 – Invitrogen, USA) 
DTT, 100mM (Sigma-Aldrich, USA) 
Eagle’s minimum essential medium (RPMI-1640 - Invitrogen, USA) 
ERCC Spike-in control mix, 1/1000 (Invitrogen, USA) 
Ethylenediaminetetraacetic acid (EDTA - Invitrogen, USA) 
Foetal bovine serum (FBS – Invitrogen, USA) 
Isopropyl alcohol (Scharlau, Spain) 
KAPA HiFi™ HotStart ReadyMix, 2× (Kapa Biosystems Inc., USA) 
KAPA SYBR® FAST qPCR Master Mix Universal (Kapa Biosystems Inc., USA) 
MgCl2, 250 M (prepared in lab) 
NEBNext® Fragmentation Buffer (New England Biolabs, USA) 
Nextera DNA Library Preparation Kit (Illumina, USA) 
Oligonucleotide dT30VN (RCD oligo-dT - Integrated DNA Technologies, USA) 
PCR and qPCR primers (Integrated DNA Technologies, USA) 
Phosphate buffered saline (PBS) solution (prepared in lab, Appendix 5.8.3) 
PrimeScript™ Reverse Transcriptase, 200 U/µL (Takara Bio Inc., Japan) 
PrimeScript™ Buffer, 5X (Takara Bio Inc., Japan) 
RNase inhibitor (Qiagen, USA) 
Template switch oligonucleotide (TSO) containing Biotin, 10µM (Integrated DNA Technologies, 
USA) 
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TURBO™ DNase (Thermo Fisher Scientific, USA) 
Triton X-100 detergent, 10% (Sigma-Aldrich, USA) 
Trypan blue (Bio-rad, USA) 
UltraPure™ DNase/RNase-Free Distilled Water (Invitrogen, USA) 
 
2.1.2 Equipment 
0.6mL microtubes (Axygen, USA) 
1 mL cryotube (Nalgene Labware, USA) 
1.5 mL microtubes (Axygen, USA) 
10 mL Serological pipettes (Greiner Bio-One, Germany) 
15mL Falcon tubes (BD Biosciences, USA) 
25mL cell culture flasks (Greiner Bio-One, Germany) 
50mL Falcon tubes (BD Biosciences, USA) 
75mL cell culture flasks (Greiner Bio-One, Germany) 
Agilent 2100 Bioanalyser High Sensitivity DNA Assay (Agilent Technologies, Germany)  
Applied Biosystems GeneAmpTM PCR system 2700 cycler (Thermo Fisher Scientific, USA) 
Applied Biosystems 7900HT Fast Reat-Time PCR system (Thermo Fisher Scientific, USA) 
Centra 3C centrifuge (International Equipment Company, USA) 
CO2 cell culture incubator (Binder, Germany) 
Dual chamber cell counting slides (Bio-Rad, USA) 
Express SC250EXP SpeedVac™ Concentrator System (Thermo Fisher Scientific, USA) 
Milli-Q Ultrapure Water Purification System (Millipore, USA) 
MiSeq System (Illumina, USA) 
Mr. Frosty 5100 Cryo 1ºC Freezing Container (Thermo Fisher Scientific, USA) 
Nanodrop ND-1000 Spectrophotometer (Nanodrop Technologies, USA) 
Qubit High Sensitivity DNA assay (Thermo Fisher Scientific, USA) 
RNeasy® MinElute® Cleanup spin columns (Qiagen, USA) 
TC10 Automated Cell Counter (Bio-Rad, USA) 
Tissue culture hood (EMAIL, Australia 




2.2 Single cell whole transcriptome analysis methodology overview 
 
Figure 2.1 – Reaction flow diagram 





2.3 Experimental design 
We applied our amplification method to three major whole transcriptome analysis 
experiments: 
i. Detecting single PC3 cells in a background population consisting of 29 HeLa 
cells; 
ii. Detecting single LNCaP cells in a background population consisting of 29 HeLa 
cells; and 
iii. Detecting single PC3 cells in a background population consisting of 199 LNCaP 
cells. 
The basic method of detecting a prostatic transcriptome signature in background 
populations consisted of first determining the up-regulated genes in a pure prostatic 
population (e.g. 30 PC3 cells) compared to a pure background population (e.g. 30 
HeLa cells). We then sought to determine if these up-regulated genes (e.g. a PC3 or 
prostatic signature) were also up-regulated in the background populations spiked 
with a single prostatic cell (e.g. 1 PC3 cell in 29 HeLa cells) compared with pure 
background populations (e.g. 30 HeLa cells).  
 
We surmised that the single prostate derived cell was detected in background if the 
prostatic signature was up-regulated in both comparisons (Figure 2.2). The genes 
that were up-regulated in both comparisons were considered for prostatic cell 











2.4 Cell lines 
Human prostate cancer cell lines (LNCaP and PC3) and a cervical cancer cell line 
(HeLa) were cultured to study a single prostate cancer cell separately as well as in a 
background population of HeLa cells. 
 
The LNCaP, PC3 and HeLa cell lines were purchased from the American Type Culture 
Collection (ATCC). 
 
2.5 Complete growth media 
The complete growth medium for culturing of LNCaP cells consisted of RPMI 1640 
media supplemented with 10% FBS. The complete growth medium for PC3 and HeLa 
cultures was a 1:1 mixture of Dulbecco’s modified Eagle’s medium and F12 medium 
(DMEM-F12) supplemented with 10% FBS.  
 
Figure 2.2 – Method for detecting single cells 
Diagram illustrating the basic experimental design for detecting genes in a cell mixed 
with an unrelated background population 
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2.6 Cell culture seeding 
Cryotubes of frozen cells for each cell line that had been stored in liquid nitrogen 
were quickly thawed in a 37ºC water-bath. Thawed cells were then re-suspended in 
4mL of warm growth medium, centrifuged for five minutes at 500 rpm, and the 
supernatant was discarded to remove the remaining DMSO. Cells were re-suspended 
in 3mL growth medium and added to a 25 mL cell culture flasks. 
All cells were subsequently incubated at 37ºC and 5% CO2 in a CO2 incubator. The 
media was changed the following day.  
 
2.7 Cell culture maintenance 
All cell lines were grown at 37ºC, with 5% CO2 in respective media. Cells were 
inspected using inverted microscope for morphology and bacterial infection at least 
once every 2 days. Media was changed every three to four days. When cultures 
reached 90% confluency they were passaged into a new 25mL cell culture flask and a 
cryotube for cryopreservation or harvested for analysis (Figure 2.3). To prevent 
genetic drift, cells beyond passage 20 were not used for any downstream analysis 






Figure 2.3 – Prostatic cell cultures 




Passaging was performed by first removing the media by an aspirator and cells were 
then washed with 1.0 mL warm phosphate-buffered saline (PBS). The PBS was then 
aspirated. For LNCaP, 1.0 mL of versene (0.58g EDTA:1L DPBS) was added, 
immediately followed by 1.0 mL EDTA Trypsin (0.05% Trypsin : 0.53mM EDTA). For 
other cell lines, 1.0 mL of Trypsin only (0.05%) was added. The cells were returned to 
the incubator to allow the Trypsin to disassociate the cells in suspension. Versene is 
used for LNCaP cells to assist with disassociation because this cell line is particularly 
agglomerated.  
 
Following Trypsinisation, 1 mL of medium was added to the trypsin containing cells. 
The cell re-suspension was then transferred to a 15 mL centrifuge tube. The cells 
were then pelleted at 500 rpm for 5 minutes. The medium was aspirated 
immediately after centrifugation and the cell pellet was re-suspended in 5 mL warm 
complete medium. 3 mL of this cell containing medium was then pipetted into a new 
2 mL cell culture flask. The remaining 2 mL of medium was either discarded or used 
for cell harvesting for analysis.  
 
Cells were plated at approximately the densities detailed in Table 2.1 and checked 
daily for confluence and bacterial contamination. Cells tend to become unhealthy 
when contaminated with bacteria as this causes their mRNA profiles to deviate from 
that of a healthy cell, rendering the sample unsuitable for analysis. 
Cell densities 
Cell line No. of cells pipetted in flask 
HeLa 1.0 x 105 
PC3 1.0 x 105 
LNCaP 2.0 x 105 
Table 2.1  




Following trypsinisation and centrifugation, pelleted cells were re-suspended in 
room temperature (25ºC) cell culture freezing media (Appendix 5.8). The cells in 
freezing media were aliquoted into cryotubes (1.0 mL each) at a density of 1.0 x 106 
cells per aliquot and transferred to a Nalgene Cryotube 1ºC freezing container 
(Nalgene Labware™) containing 100% isopropyl alcohol. This container was then 
placed in a -80ºC freezer. This enabled the cells to be gradually cooled to -80ºC at a 
rate of -1ºC minute-1. Once cooled to -80ºC (within 2 days after being placed in the -
80ºC freezer), the cryotubes were stored in liquid nitrogen. 
 
2.9 Determination of cell concentration and viability 
Cell concentration was determined using an automated cell counter (TC20™ 
Automated Cell Counter, Bio-rad USA) and viability was determined with trypan 
blue. 20µL of re-suspended cells was added to 20µL of trypan blue and incubated for 
2 minutes. 10µL of this cell-trypan blue mixture was pipetted onto a slide for 
automated counting. 
 
2.10 Cell harvesting and isolation 
In the final step of passage, the remaining 2 mL of the 5 mL medium containing cells 
was pipetted into a new 15mL centrifuge tube. This cell suspension was centrifuged 
at 500 rpm for 5 minutes. The medium was then aspirated and the cell pellet was re-
suspended in 1mL of PBS. The cells were then counted and diluted with PBS to 100 
cells µL-1. The cells are easier to manipulate for harvesting with a light microscope-
guided mouth suction micro-pippette at this dilution. 
 
1 mL of PBS containing 100 cells µL-1 was aliquoted to a 1.5 mL Eppendorf tube. 5 µL 
of PBS containing 100 cells µL-1 was transferred to a microscope slide. The light 
microscope magnification was set to the 40x objective. A micromanipulator was 
used to advance the micropipette toward the solution on the slide into the light 
path. When the pipette tip was touching the cell soma to be harvested, gentle 
suction by mouth was used until the cell entered the pipette tip. The harvested cell 
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or cells were then deposited into strips of 0.2 ml thin-walled PCR tubes in the lowest 
possible volume of H2O (preferably ≤1 μl). The harvested cells were then stored at -
80ºC.  
 
Cells were harvested as quickly as possible while outside of the incubator. This is 
because the cells tend to become unhealthy when at temperatures lower than 37ºC 
and this causes their mRNA profiles to deviate from that of a healthy cell. All single 
cells and bulk cells of the same type were derived from the same passage and cell 
culture. 
 
2.11 Preparation for reverse transcription 
Reaction mix 1 (Table 2.2) was prepared in a 1.5 mL low bind Eppendorf tube. The 
Triton detergent assisted in maximizing cell lysis and RNase inhibitor assisted in 
protecting mRNA from RNase activity. The External RNA Controls Consortium (ERCC) 
control mix allows the assessment of the fidelity of the amplification method. This 
control mix consists of pre-formulated blends of 92 transcripts, derived and 
traceable from NIST-certified DNA plasmids. The transcripts are designed to be 250 
to 2,000 nt in length, which mimic natural eukaryotic mRNAs. DNase I was not added 














Figure 2.4 – RCD oligo-dT construct 
The 30 thymidine residues at the 5’ end of the construct binds to the 3’ poly-adenosine tail of 
mature mRNA. The random residue (V) enables the construct to bind to the region where the 
adenosine tail is joined to the coding region. 
	
Reaction mix 1 
Component Total volume (µL) 
UltraPure™ DNase/RNase-Free Distilled 
Water (Invitrogen™) 
87 
RNase inhibitor (Enzymatics™) 5 
Triton X-100 detergent (10%, Sigma-
Aldrich®) 
4 
dNTP Mix (10mM, Invitrogen™) 100 
ERCC Spike-in control mix, 1/1000 
(Invitrogen™) 
6 
Table 2.2  
Reagents added to mRNA samples to prepare for reverse transcription step. 
 
2.5 µL of reaction mix 1 was added to each of 40 uniquely bar-coded 2.5 µL aliquots 
of anchored oligonucleotide dT30VN (RCD oligo-dT, 12ng/µL) in a 96-well plate. The 
RCD oligo-dT contained a unique 8 bp barcode, reverse transcription primer, a 
forward PCR primer, a T7 IVT promoter for downstream amplification and a 3’ 
forward sequence linker (Figure 2.4). We used 40 unique barcodes that enabled us 
to process up to 40 samples at a time and combine them in downstream reactions 
and on a single sequencing lane.  This feature enabled us to carry out three 








The harvested cell aliquots were thawed after having been in -80°C conditions for at 
least 3 hours. The freeze/thaw resulted in partial lysis of the cell membrane and 
release of the mRNA for reverse transcription. RNA samples were always placed in 
ice and were processed without delay to avoid substantial degradation of the single 
cell pico-gram amounts of RNA. The 5 µL reaction mix 1 with oligo-dT was added to 
PCR tubes containing RNA. A multi-channel manual Biopette pipette was used to 
combine and mix the solution to reduce labour (Figure 2.5). 
 
This mixture was then incubated at 72°C for 3 min and immediately put back on ice. 
This enabled the anchored oligo-dT primer to hybridize to the beginning of the poly-
A tail of all the mRNA molecules.  
 
 
Figure 2.5 – Incorporation of the oligo-dT construct 
40 uniquely barcoded RCD oligo-dTs were each mixed with reaction mix 1 and then added to 40 
RNA samples. This mixture was then incubated, allowing the oligo-dT to anneal to the beginning 





2.12 Reverse transcription of mRNA to cDNA 
5.7µL of reverse transcription mix 1 (RT mix 1) was added to each sample. RT mix 1 
was pre-prepared for all reactions, plus one ghost sample to account for pipetting 
inaccuracies, by combining and mixing the reagents listed in Table 2.3.   
 
Reverse transcription mix 1 
Component Volume per reaction (µL) 
PrimeScript™ Reverse Transcriptase (200 U/µL, 
Takara Bio Inc.) 
0.5 
PrimeScript™ Buffer (5X, Takara Bio Inc.) 2.14 
DTT (100mM,  Sigma-Aldrich®) 0.25 
Betaine (5 M, Sigma-Aldrich®) 2 
Template switch oligonucleotide (TSO) 
containing Biotin (10µM) 
0.6 
MgCl2 (250 M) 0.24 
Table 2.3 
Components of the first reverse transcription reaction. 
 
After RT mix 1 was added to each sample, the reactions were incubated in a Applied 
Biosystems GeneAmp™ PCR system 2700 cycler according to the protocol in Table 
2.4. Reactions were stored at 4ºC. The mRNA has now been converted to cDNA with 
a forward PCR primer on the 5’ terminal and a reverse primer contained in the TSO 
incorporated on the 3’ terminal. The cDNA can therefore by amplified in a PCR ‘pre-




Reverse transcription protocol 
Cycle Step TEMP Time Cycles 
Reverse transcription and 
template switching 
420 C 90 min 1 
RTase inactivation 750 C 15 min 1 
Hold 40 C - 1 
Table 2.4 
Protocol for the first reverse transcription reaction. 
 
2.13 PCR pre-amplification 
19µL of PCR mix 1 was added to each sample. PCR mix 1 was pre-prepared for all 
reactions plus one by combining and mixing the reagents listed in Table 2.5. 
 
Polymerase chain reaction mix 1 
Component Volume per reaction (µL) 
KAPA HiFi™ HotStart  
ReadyMix (2×) 
15 
Forward primer (0.5 µM) 0.5 
Reverse primer (0.5µM) 0.5 
UltraPure™ DNase/RNase-Free 
Distilled Water (Invitrogen™) 
3 
Table 2.5 
Components for the first polymerase chain reaction. 
 
Amplification was then performed in an Applied Biosystems GeneAmp™ PCR system 
2700 cycler according to the incubation protocol in Table 2.6. All samples were 
amplified with 18 cycles. The Agilent 2100 Bioanalyser High Sensitivity DNA assay 
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determined the yield and quality of the pre-amplified double stranded cDNA. The 
reactions were stored at 4ºC. 
Polymerase chain reaction protocol 1 
Cycle Step TEMP Time Cycles 
Initial denaturation 980 C 3 min 1 
Denaturation 980 C 20 sec 18 
Annealing 700 C 15 sec 18 
Extension 720 C 6 min 18 
Final extension 720 C 5 min 1 
Hold 40 C - 1 
Table 2.6 
Protocol for the first polymerase chain reaction. 
  
2.14 PCR purification 
The 40 PCR pre-amplified cDNA samples were combined into 5 aliquots in 1.5mL 
Eppendorf tubes and the volume of each aliquot was reduced to 100 µL by using a 
vacuum centrifuge (Express SC250EXP SpeedVac™ Concentrator System, Thermo 
Fisher Scientific, Inc.). The vacuum centrifuge was pre-heated to 65ºC and the 
samples were centrifuged for 30 minutes or until the sample volume reached 100 µL. 
60µL of Ampure® XP magnetic beads (Beckman Coulter) were added to the vacuum 
centrifuged samples (0.6:1 ratio). 
 
The 5 combined cDNA samples were purified following the instructions of Picelli et 
al., (2014), steps 17-22. The samples were eluted into 30µL of nuclease free H2O in 
fresh 0.2mL thin-walled PCR tubes. The 5 samples can then be sequenced at this 
point according to the Nextera DNA Library Preparation Kit (Illumina, Inc.) protocol. 
However, we combined the 5 samples into a single volume and for further 
processing by an IVT step described in this protocol. 
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2.15 In vitro transcription (IVT) 
The single combined PCR sample was further amplified by conducting a single round 
of IVT to convert the cDNA into aRNA. This was done using the Ambion™ 
MessageAmp™ II aRNA amplification kit, as per the kit manual (Part Number 
AM1751); we followed step IIF for an unmodified 40µL reaction. The IVT was 
incubated at 37ºC for 14 hours using an Applied Biosystems GeneAmp® PCR system 
2700 cycler (Thermo Fisher Scientific, Inc.).  
 
2µL of TURBO™ DNase (2 Units/μL, Life Technologies) was added immediately after 
the IVT incubation. The reaction was incubated with the TURBO™ DNase at 37ºC for 
15 minutes using an Applied Biosystems GeneAmp™ PCR system 2700 cycler and 
then placed immediately on ice. 
 
The RNA was fragmented with 9µL of NEBNext® Fragmentation Buffer (10X) and 
incubated at 94ºC for 90 seconds, then 2µL of NEBNext® 10X Fragmentation Stop 
Solution was added to cease the fragmentation reaction. The reaction was then 
brought up to 100µL with nuclease-free water, as per the Ambion™ MessageAmp™ II 
aRNA amplification kit manual, and placed on ice. 
 
The IVT reaction was then cleaned up by RNeasy® MinElute® Cleanup spin columns 
(Catalogue no. 74204), as per the manufacturer’s instructions. The sample was 
eluted into a 0.5 mL Eppendorf tube by 14µL of nuclease-free water that was pre-







2.16 Reverse transcription of aRNA to cDNA  
The aRNA was reverse transcribed back to cDNA by adding 8µL of reverse 
transcription mix 2 (RT mix 2) to a 2µL aliquot of the aRNA sample. RT mix 2 was pre-
prepared by combining and mixing the reagents listed in Table 2.7. 
 
Reverse transcription mix 2 
Component Volume per reaction (µL) 
PrimeScript™ Reverse Transcriptase (200 
U/µL, Takara Bio Inc.) 
1 
Primescript™ Buffer (5X, Takara Bio Inc.) 2 
Oligonucleotide (Oligo) 2* 1 
UltraPure™ DNase/Rnase-Free Distilled Water 
(Invitrogen™) 
4 
Template switch oligonucleotide (TSO) 
containing Biotin (10µM) 
0.6 
MgCl2 (250 M) 0.24 
Table 2.7 
Components of the second reverse transcription reaction. 
 
The RT reaction was incubated according to the protocol in Table 2.8. The reaction 









Reverse transcription protocol 2 
Cycle Step TEMP Time Cycles 
Initial denaturation 250 C 5 min 1 
Reverse transcription 370 C 30 min 1 
RTase inactivation 850 C 1 min 1 
Hold 40 C - 1 
Table 2.8 
Protocol for the second reverse transcription reaction. 
 
The RT product was purified by Ampure XP® magnetic beads (Beckman Coulter). 12.5 
µL of the magnetic beads were added to the 10 µl RT product and it was purified 
following the instructions of Picelli et al. (2014), steps 17-22. The RT product bound 
to magnetic beads was eluted in 50 µL PCR mix 2 (see Table 2.9) for library 
amplification by a second PCR. The reverse PCR primer contained the reverse 


















Polymerase chain reaction mix 2 
Component Volume per reaction (µL) 
KAPA HiFi™ HotStart ReadyMix (2×) 20 
Forward primer (0.5 µM) 2.5 
Reverse primer (0.5 µM)† 2.5 
UltraPure™ DNase/RNase-Free 
Distilled Water (Invitrogen™) 
20 
Table 2.9 
Components for the second polymerase chain reaction. 
 
In summation, the addition of the reverse PCR priming site during the second RT 
produced a library with the full complement of sites required to generate a finished 
library suitable for PCR paired-ended sequencing. Forward and reverse primers used 
during PCR incorporated 5’ and 3’ sequencing linkers into the PCR product. 
Amplification was then performed in an Applied Biosystems GeneAmp™ PCR system 













Polymerase chain reaction protocol 2 
Cycle Step TEMP Time Cycles 
Initial denaturation 980 C 5 min 1 
Denaturation 980 C 30 sec 6 
Annealing 650 C 30 sec 6 
Extension 720 C 15 sec 6 
Final extension 720 C 5 min 1 
Hold 40 C - 1 
Table 2.10 
Protocol for the second polymerase chain reaction. 
 
50µL of Ampure® XP magnetic beads were added to the 50µL RT product sample (1:1 
ratio). The sample was purified following the instructions of Picelli et al. (2014), steps 
17-22. The samples were eluted into 30µL of nuclease free water in a fresh 0.2mL 
thin-walled PCR tube. 
 
The Agilent 2100 Bioanalyser High Sensitivity DNA assay determined the purified 
DNA yield, quality and size. The Qubit High Sensitivity DNA assay determined the 
DNA quantity.  The sample was diluted to 4 nM for DNA sequencing. 
 
2.17 RNA sequencing 
We performed single-end 150 base length sequencing of the DNA library using an 
Illumina MiSeq instrument at the University of Otago, Department of Biochemistry, 
as per the manufacturer’s instructions. The sequencing took approximately 21 hours. 
 
The cDNA libraries were prepared for sequencing by Dr Robert Day through 
tagmentation using the Nextera XT library preparation kit, following the user manual 
instructions. We performed single-end 150 base length sequencing of the DNA 
library. This was done using an Illumina MiSeq instrument at the University of Otago, 
Department of Biochemistry, as per the manufacturer’s instructions. The sequencing 
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took approximately 21 hours. 22-25 million reads are regularly obtained from a 
single lane for an Illumina MiSeq when performing single-end 150 base length 
sequencing. We multiplexed 40 libraries in a single lane, which means an average 
sequencing depth of between 550,000 and 625,000 reads can be obtained from each 
of the 40 libraries.  
 
2.18 Data processing and statistical analysis 
Raw sequences and quality scores in FastQ format were exported from Illumina 
BaseSpace for all clusters that passed filtering. The 40 libraries were de-multiplexed 
by the unique barcodes using the Sabre software package 
(https://github.com/najoshi/sabre). Linkers were removed and reads trimmed to 49 
bp and any reads less than 20 bp were removed to increase read quality while 
maintaining specificity (Moreton, et al., 2014). 
 
The read data was aligned to human genome build GrCh37 using the Bowtie2 and 
Cufflinks software packages. The aligned files were converted to BAM/SAM files by 
Bowtie 2 and imported into SeqMonk 
(http://www.bioinformatics.babraham.ac.uk/projects/seqmonk). SeqMonk was used 
to annotate mRNA splice variants (herein referred to as ‘gene isoforms’) and 
quantify reads mapping to gene isoforms. Gene isoforms making up the 
transcriptome were annotated using the gene or mRNA probe generator functions of 
SeqMonk. The single cell data from Ramsköld et al. (2012) was imported into 
SeqMonk in the BED file format from the Gene Expression Omnibus (accession 
number GSE38495). 
 
SeqMonk’s RNA quantitation pipeline was used for single cell sample analysis only 
(see section 3.2 of Chapter 3). The transcript feature option was set to ‘gene’. 
Spliced transcripts were merged into a single representative value and corrected for 
DNA contamination. SeqMonk’s ‘mRNA feature probe generator’ was used for single 
cell detection in a milieu (see section 3.3 of Chapter 3), without using a SeqMonk 
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analysis pipeline. The SeqMonk genome annotations are based on the Ensembl 
releases of GRCh37 in 2015. 
 
The raw counts for samples with the same number of cells were normalized to the 
total read count by scaling up all the reads for each sample to the largest datastore 
using SeqMonk. Ramsköld et al. (2012) data was gene length corrected by converting 
expression to the RPKM unit using SeqMonk. Feature reports were generated with 
exactly overlapping probes for each analysis and converted to CSV files for further 
gene expression analysis with the R statistical programming language. 
 
Data formatting, log2 transformations, volcano plots, MA plots, dendrogram 
hierarchical clustering, bootstrap calculations, heatmaps and k-medoid (Partitioning 
Around Medoids) clustering of principal components were done using R packages (R 
Core Team, 2017; Reynolds et al., 1992). Data for principal components analysis and 
heatmaps was further normalized by the standard deviation. 
 
For the principal components analysis (PCA), the first two principal components that 
captured the most variance were clustered according to the partitioning around 
medoids (PAM) algorithm. Volcano plots depict the common differential expression 
values for each gene isoform across sample replicates. Differential gene isoform 
expression analysis was computed by empirical Bayes statistics using the LIMMA 
package in R (Smyth, 2004).  
 
P values were calculated by unpaired, two-tailed T tests where the variances were 
treated as being equal and the pooled variance was used to estimate the overall 
variance. Two-tailed T tests were also used to calculate the 95% confidence intervals. 
Appendix 5.10 refers to the specific packages used and R code for each type of 
analysis. P values in volcano plots were converted to negative natural logarithmic (-
log) values. P values were adjusted for multiple testing by controlling the false 
discovery rate with the Benjamini & Hochberg (1995) method. 
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Read coverage of gene isoforms was assessed with the ‘Probe Trend Plot’ function of 
SeqMonk. The quality of normalization was assessed by the ‘Cumulative Distribution 
Plot’ function in SeqMonk. Data for heatmaps and principle components analysis 
were normalized by standard deviation using the mean. 
 
2.19 qPCR primer design 
Quantitative real-time PCR (qPCR) with SYBR green dye was used to compare the 
level of putative gene expression of MAGED1 and PSA, relative to the Beta Actin 
housekeeping gene. This was conducted between the LNCaP and PC3 cell lines at a 
population level. This assisted in confirming the sequencing data.  
The Primer3Plus software generated various combinations of primer sequences for 
MAGED1. The qPCR settings of Primer3Plus were used. The appropriate primer pair 
was selected after taking into consideration the following (Udvardi et al., 2008): 
1. Primer Length 
The optimal primer length is 18-25 bp. This length allows for specificity. 
2. Primer Melting Temperature (Tm) 
Tm is defined as the temperature at which half of the DNA duplex will 
dissociate to become single stranded, and indicates duplex stability. Udvardi 
et al. (2008) suggest a Tm of 60ºC +/- 1ºC for qPCR. 
3. Primer annealing temperature 
Normal annealing temperatures are between 50 and 65ºC. Higher annealing 
temperatures may produce insufficient primer template hybridization 
resulting in lower PCR product. Lower annealing temperatures tend to result 
in non-specific products. Both forward and reverse primers should have 
annealing temperatures that are similar. 
4. Guanine – Cytosine (G+C) content 
The recommended G+C content of qPCR primers is between 40% and 60%. 
5. Avoid cross homology 
A BLAST analysis of the primer sequences against the NCBI server was 
performed to test for specificity. 
6. Amplicon Length 
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Maximum amplicon size should not exceed 400 bp (ideally 50-150 bases).  
7. Runs and Repeats 
 The probes should not have runs of identical nucleotides (especially four or 
more consecutive Gs), G+C content should be 30-80%, there should be more 
Cs than Gs, and not a G at the 5' end.  
 
2.20 qPCR primers 
Table 2.11 illustrates the qPCR primer sequences for quantifying the relative genetic 
expression of MAGED1 and PSA. The PSA qPCR primers are from Hessels et al., 2003. 
 
Gene name MAGED1 PSA (KLK3) 
Forward primer  5ʹ-CCTGCCTCATCCTTTAACCA-3ʹ 5ʹ-AGCATTGAACCAGAGGAGTTCT-3ʹ 
Reverse primer 5ʹ-CCAATTGTTCTTGCCATCCT-3ʹ 5ʹ-CCCGAGCAG GTGCTTTTG-3ʹ 
Region amplified Nucleotides 10417-10645, inside 
intronic region (NCBI Reference 
Sequence: NG_012559.1).  
Nucleotides 4024-5700, spanning 
exons 3, 4 and 5 (GenBank 
#M27274). 
Table 2.11 
qPCR primer sequences for analysis of MAGED1 and PSA gene expression. 
 
2.21 RT-qPCR protocol 
The harvested cell line aliquots were thawed, resulting in lysis of the cell membrane 
and release of the RNA for reverse transcription. RNA samples were always placed in 
ice. The RNA quantity was measured by the Nanodrop 1000 Spectrophotometer 
(Thermo Fisher Scientific Inc.).  The RNA from both cell lines was diluted in the 
appropriate volume of nuclease-free water so that both PC3 and LNCaP RNA was 
present at 15 ng/µl. 15 ng of RNA from either cell line was added to RT-qPCR 






RT-qPCR reaction mix 1 
Component Total volume (µL) 
UltraPure™ DNase/RNase-Free Distilled 
Water (Invitrogen™) 
2.5 
RNase inhibitor (Enzymatics™) 1 




Reagents added to mRNA samples to prepare for RT-qPCR. 
 
This mixture was then incubated at 72 °C for 3 min and immediately put back on ice. 
This enabled the anchored oligo-dT primer to hybridize to the beginning of the poly-
A tail of all the mRNA molecules.  
 
5.7µL of reverse transcription mix 3 (RT mix 3, see Table 2.13) was added to each 
sample. RT mix 1 was pre-prepared for all reactions plus one by combining and 
mixing the reagents listed in Table 2.2.   
 
Reverse transcription mix 3 
Component Volume per reaction (µL) 
PrimeScript™ Reverse Transcriptase (200 
U/µL, Takara Bio Inc.) 
0.5 
PrimeScript™ Buffer (5X, Takara Bio Inc.) 2.14 
DTT (100mM,  Sigma-Aldrich®) 0.25 
Betaine (5 M, Sigma-Aldrich®) 2 
MgCl2 (250 M) 0.24 
Table 2.13 
Components of the reverse transcription reaction for qPCR. 
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After RT mix 3 was added to each sample, the reactions were incubated at 42ºC for 
90 minutes and then at 70ºC for 15 minutes in a Applied Biosystems GeneAmp™ PCR 
system 2700 cycler. Reactions were stored at 4ºC. The mRNA has now been 
converted to cDNA. The 10 µL cDNA reaction is diluted in 90 µL of nuclease-free 
water to prevent the reverse transcription reagents interfering with the qPCR 
reaction. 
 
Each sample was run in triplicate on the CFX Connect™ Real-Time PCR Detection 
System. Sterilized water was used as a no template control (NTC). 5.48 µL of qPCR 
reaction mix (see Table 2.14) was added to 4 µL of the cDNA, 4 µL of the water 
control and 4 µL of a reverse transcription reaction lacking a reverse transcriptase 
enzyme as an RT- control.  
 
qPCR reaction mix 
Component Volume per reaction (µL) 
KAPA™ SYBR® FAST qPCR Master Mix Universal 
(Kapa Biosystems Inc.) 
5 
Forward primer (20mM) 0.14 
Reverse primer (20mM) 0.14 




Components of the qPCR. 
 








Cycle Step TEMP Time Cycles 
Initial denaturation 950 C 3 min 1 
Denaturation 950 C 15 sec 45 
‡Anneal/Extension 600 C 1 min 45 
Disassociation curve 
initiation 
650 C - 1 
Annealing gradient 0.50 C - 950 C * - 
Table 2.15 
Protocol of the qPCR. 
 
2.22 qPCR analysis 
Standard curves were generated to quantify gene expression. qPCR runs were 
considered successful if the slope of the standard curve was between -3.10 and -
3.50, the correlation coefficient was above 0.98 and triplicates were within 0.5 of a 
threshold cycle of each other. A disassociation curve was also run to ensure the 
absence of non-specific product. Bar graphs representing quantification of gene 
expression were generated with the ggplot2 package for R. Quantification was 
normalized to the Beta-actin housekeeping gene (Raff et al., 1997) 
 
2.23 Personnel contributions 
Dr. Robert Day developed the method and conducted the PC3 and LNCaP in HeLa 
mix experiments. Tanis Godwin operated the micro-pipette to pick the cells. The 
author cultured all the cells and conducted the LNCaP in PC3 mix experiment while 
Dr. Robert Day ran this experiment on the Illumina Mi-seq instrument. The author 






DNA assay while Dr. Robert Day resolved this issue by attaching a biotin molecule to 






The first aim of this project was to troubleshoot a method to measure global gene 
expression of individual cells. This chapter presents the results from troubleshooting 
the method and three major whole transcriptome experiments outlined in Chapter 2, 
section 2.2. Each of these experiments were conducted on separate Illumina MiSeq 
sequencing runs. 
 
Results from troubleshooting and optimization of our methodology are presented first 
(section 3.1), followed by an analysis of single cell transcriptomes (section 3.2). We 
compared these single cell transcriptomes to single cell LNCaP and PC3 data generated 
by the method described by Ramsköld et al., (2012).  
 
In section 3.3 we present results on the detection of a single PC3 or LNCaP cell in an 
unrelated background population of cells (either 29 HeLa cells or 199 LNCaP cells). All 
single cell and multi-cell transcriptomes were sequenced using the method described 














3.1 Optimal PCR pre-amplification of the cDNA library 
Prior to applying the method to single cell samples, it was necessary to optimize the 
initial PCR pre-amplification (see methodology in section 2.12). We used the Agilent 
2100 Bioanalyser High Sensitivity DNA assay to establish the optimal yield and quality 
of the cDNA library following the initial reverse transcription. Significant artifact noise 
in the cDNA library produced from the initial RT-PCR (following sections 2.9 - 2.13) had 
to be resolved before the method could be applied to single cells from cell culture.  
 
3.1.1 Resolving artifacts in the cDNA library 
The first major hurdle for amplifying the reverse transcribed cDNA by PCR was to 
remove artifacts from the PCR product. The most prominent artifact was a ‘hedgehog’ 
pattern most likely caused by concatenation of the TSO end of the cDNA (Figures 3.1A 
and 3.1C). Figure 3.1 demonstrates that this artifact is resolved by using a biotin 
molecule attached to the 5’ end of the TSO (Figures 3.1B and 3.1D). This blocked 
artificial expansion of the 5’ end of the cDNA. We compared 1ng/µl and 10pg/µl of PC3 
derived RNA template. The wide library spread in trace C indicates RNA degradation 













Figure 3.1 – cDNA library profile with and without the biotin TSO                               
Agilent 2100 Bioanalyser High Sensitivity DNA assay electropherogram traces of cDNA libraries were 
obtained from  RT-PCR of RNA derived from lysed aggregate PC3 cells and diluted to 1ng/µl (A, B) and 
10pg/µl (C, D). DNA amount is measured in fluorescence units (FU). Peaks at 35 bp and 10380 bp are 
gel migration markers. Traces A and C are representative examples of the characteristic ‘hedgehog’ 
pattern in samples using the biotin negative TSO. Traces B and D are representative examples of a 







3.1.2 Optimal PCR polymerase 
The second consideration was ensuring the appropriate Taq polymerase was selected 
for optimal PCR pre-amplification. We assessed the amplification efficiency of Kapa 2G 
Robust polymerase and Kapa HiFi Hotstart polymerase (Kapa Biosystems). The RNA 
template was the HeLa RNA control from the Ambion™ MessageAmp™ II aRNA 
amplification kit. We assessed polymerase activity on 100ng/µl and 10ng/µl of RNA 
template derived from PC3 cells. Library quality and yield was assessed by examining 
the electropherogram produced from the Bioanalyser assay of the cDNA product 
(Figure 3.2).  
 
The electropherogram profile of a successful cDNA pre-amplification is a prominent 
peak between  ~1.5 – 2 kb (Picelli et al., 2014). Kapa 2G Robust polymerase produces a 
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Figure 3.2 – cDNA library profile of two PCR polymerases.   
Agilent 2100 Bioanalyser High Sensitivity DNA assay electropherogram traces of cDNA libraries were 
obtained from RT-PCR of RNA derived from HeLa RNA control and diluted to 100ng/µl (A, B) and 
10ng/µl (C, D). DNA amount is measured in fluorescence units (FU). Peaks at 35 bp and 10380 bp are 
gel migration markers. Traces B and D are representative examples of a successful cDNA library using 
the Kapa HiFi HotStart polymerase. Traces A and C are representative examples of a cDNA library 
amplified by Kapa 2G Robust polymerase.  
wider range of fragments, particularly under 200 bp at smaller RNA concentrations. 















3.2 RNA-seq of single cells 
We applied our single cell transcriptome amplification method to sixteen isolated 
single cells, eight from each of the PC3 and LNCaP cell lines (following sections 2.2 - 
2.17). The eight single cells from each cell line were multiplexed in a single MiSeq 
sequencing run. Ramsköld et al., (2012) also quantified four PC3 and four LNCaP single 
cell transcriptomes with their PCR based method, dubbed ‘Smart-Seq’. This PCR 
method developed into ‘SMART-Seq2’ (see section 1.4.3) by Picelli et al., (2013, 2014). 
We compared the characteristics of our different approaches.  
 
All libraries, including data from Ramsköld et al., (2012), were quantitated with the 
RNA-Seq pipeline in SeqMonk using the gene probe generator. Isoforms for each gene 
were merged into a single measure with reads counted over exons only. This resulted 
in a total of 33,175 gene features that were quantified. 
 
3.2.1 Genes detected per read 
Ramsköld et al.’s sequencing approach used a single MiSeq run for each individual cell, 
so that the 20 million read capacity of the MiSeq sequencing platform was 
concentrated on one cell at a time. In contrast, our approach involved multiplexing 568 
cells per sequencing run, eight of which (PC3 or LNCaP) were barcoded single cells in 
isolation. This meant the 20 million reads of the MiSeq platform was approximately 
568 times more diluted in our single cell data compared to Ramsköld et al.’s samples. 
Consequently, our method detected significantly more genes per read on average (P < 
0.05) for both cell lines than Ramsköld et al.’s method (Figure 3.3).  
 
We detected 168 times more genes per read on average in single PC3 cells than 
Ramsköld et al., and 94 times more genes per read on average in single LNCaP cells. 
We detected up to 33% of all genes in a single cell with only 0.005% of reads used on 
average by Ramsköld et al. (Appendix 5.5, Tables 5.1 and 5.2). 
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Figure 3.3 – Genes detected per read in single cell transcriptomes.   
There were significantly more genes detected per read in our single PC3 (A) and LNCaP (B) cell 
samples (green bars) on average (red line, * = P < 0.05) compared to Ramsköld et al. (blue bars). The y 





3.2.2 Variation across single cell transcriptomes 
We quantified the degree of variability within and between single PC3 and LNCaP cell 
transcriptomes by calculating the non-log2 transformed Pearson correlations for 
Ramsköld et al.’s data and our data (Figure 3.4). Our single PC3 and LNCaP cells had 
higher median and mean Pearson correlations (P < 0.05) within cells of the same type, 
signifying more consistent transcriptomes than Ramsköld et al. (Figure 3.4C).   
 
Single LNCaP cells had a relatively higher correlation than single PC3 cells within both 
Ramsköld et al.’s samples and our samples. Our single PC3 cells had an average 
Pearson correlation of 0.90 (CI = 0.01, n = 8) compared to the average Pearson 
correlation of 0.55 (CI = 0.37, n = 4) for Ramsköld et al.’s single PC3 cells. Our single 
LNCaP cells had an average Pearson correlation of 0.94 (CI = 0.01, n = 8) compared to 







Figure 3.4 – Pearson correlations between single cells.   
Pearson correlations across single cell transcriptome expression for our data (A) and Ramsköld et al., 
(2012) (B). Figure C is a boxplot depicting the distribution of Pearson correlations for each sample set, 
with the median represented in the bold red. The median Pearson correlation for our single PC3 cells 
was 0.90 (n = 8) and for Ramsköld et al. 0.63 (n = 4). The median Pearson correlation for our single 
LNCaP cells was 0.94 (n = 8) and for Ramsköld et al., 0.90 ( n= 4). Our median Pearson correlations 
were significantly higher than Ramsköld et al. (P < 0.05). The median correlations between PC3 cells 
and LNCaP cells were relatively consistent between the two methods (our data = 0.69, Ramsköld et 











Figure 3.5 – Principal components analysis of single cells.   
PCA for single LNCaP and PC3 cells from our method and Ramsköld et al. (2012). Data points 
are shown based on the first two principal components that capture the most variance and 
clustered according to the PAM algorithm (k = 4). Reads mapped to 28,854 gene features out 
of a total of 33,175 (86%) across all single cell samples (including Ramsköld et al. (2012). 




3.2.3 Principal components analysis of single cell transcriptomes 
The transcriptome levels of single cells were analysed using principal components 
analysis (PCA) and the partitioning around medoids (PAM) clustering algorithm to 
elucidate underlying patterns. The principal component clustering demonstrates that 









Figure 3.6 – Read coverage across gene length.   
The read coverage across gene length was deliberately limited to the 3’ end to simplify the 
quantification of gene expression for our method (B). The traces in graphs A and B represent the read 
coverage over the average gene isoform which is calculated by determining the number of reads 
overlapping with each position in each probe. These quantities were plotted out as an average over 
all genes by SeqMonk (see section 2.17). 
 
 
3.2.4 Read coverage across gene isoforms 
As expected, our data had reads mapping almost exclusively to the 3’ end of gene 
probe features (Figure 3.6B). In contrast, Figure 3.6A illustrates Ramskold et al.’s 





















3.3 Single cell detection in a background population 
We applied our method to detecting single prostate cancer derived cells (from the PC3 
or LNCaP cell lines) in a mileu consisting of either HeLa cells or a different type of 
prostate cancer cell line. We did this by first determining the mRNA splice variants 
(gene isoforms) over-expressed in the prostate cancer derived cell that we were trying 
to detect, relative to the background population sample (volcano plot A in Figure 3.7). 
These gene isoforms formed the basis of the signal for the single cell that we were 
aiming to detect. 
 
Secondly, we identified the gene isoforms over-expressed in the sample containing a 
single prostate cancer derived cell in a background, relative to a pure background 
population sample (volcano plot B in Figure 3.7). Finally, we determined the most 
overly-expressed gene isoforms with a P value below 0.05 and log2 fold change >1 that 
were shared between volcano plots A and B. We treated the expression pattern of 
these shared gene isoforms as the signal for the presence of a single prostate cancer 
derived cell in the background population. We illustrated this signal in a heatmap (red 
for over-expression relative to background cells) that depicts the relative expression 
levels of the shared gene isoforms for individual samples (Figure 3.7). 
 
We also included the eight isolated single cell samples from the LNCaP or PC3 cell 
cultures in the heatmap. If the gene isoform expression pattern of these single cells in 
isolation was generally consistent with the pattern of the same single cells in the 
background population, we could be more confident that the signal was genuine. 
Libraries for single cell detection were quantitated in SeqMonk using the mRNA probe 
generator. This allowed us to quantify mRNA splice variants of genes. This resulted in a 
total of 149,135 mRNA features (gene isoforms) that were quantified. 
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Figure 3.7 – Detection of a single prostate cancer cell in a background population.   
A graphic explanation of Figures 3.8, 3.10 and 3.12. The figure illustrates the method for distinguishing 
a prostate cancer cell in a different cell background using differential gene isoform expression 
represented by two volcano plots that identify gene isoform expression specific to the prostate cancer 
(PC) cell of interest. The gene isoform expression pattern that is specific to the single prostate cancer 
cell of interest is represented by a heatmap that includes the cell in the background population, the 
cell of interest in isolation and the background cells alone. 
 The read coverage across our gene isoforms was deliberately limited to the 3’ end to simplify the 
quantification of gene expression (B). The traces in graphs A and B represent the read coverage over 
the average gene isoform which is calculated by determining the number of reads overlapping with 
each position in each probe. These quantities were plotted out as an average over all gene isoforms 












3.3.1 Detection of a single PC3 cell in 29 HeLa cells 
The volcano plots in Figure 3.8 illustrate the number of differentially expressed gene 
isoforms in PC3 cells relative to HeLa cells. We detected a single PC3 cell in 29 HeLa 
cells by 161 gene isoforms that were over expressed in both volcano plots A and B 
depicted in Figure 3.8. The most over expressed gene isoform in PC3 cells compared 
with HeLa cells is from MAGED1 (volcano plot A: log2 fold change = 9.3, P < 0.01). 
MAGED1 was also highly expressed in the single PC3 cell in the 29 HeLa cell 
background (volcano plot B: log2 fold change = 6.5, P < 0.01). MA plots for both 
volcano plots (Appendix 5.3, Figure 5.5) show slopes of the loess curves are around 1 
(horizontal) at y axis = 0, indicating that there are no systemic biases requiring further 
normalisation (Cleveland et al., 2017). 
 
In the individual samples depicted in the heatmap in Figure 3.8, only 3 out of 8 of the 
single PC3 cell in the 29 HeLa background samples exhibited MAGED1 over-expression. 
MAGED1 was overexpressed in only 5 out of 8 single PC3 cell samples. No single gene 
isoform exhibited consistent over-expression in single PC3 cells that would enable 
detection in a HeLa background. As reported previously, PC3 samples exhibited zero 





Figure 3.8 – Detection of a single PC3 cell in 29 HeLa cells.   
Volcano plots of differentially expressed gene isoforms between 30 PC3 (n = 3) and HeLa cells (n = 4) 
(A), and a single PC3 cell in 29 HeLa cells (n = 8) and 30 PC3 cells (n = 3) (B). The highly differentially 
expressed (log2 fold change >1), statistically significant (P < 0.05) gene isoforms (highlighted in red) 
that were shared between both volcano plots were analysed in a heatmap of 30 HeLa cells, a single 
PC3 cell in 29 HeLa cells and single PC3 cells alone (C). 161 gene isoforms identified the presence of a 
single PC3 cell in 29 HeLa cells (P < 0.05). The MAGED1 gene isoform was the most over expressed 
gene in PC3 cells relative to HeLa cells. The 30 PC3 cells were not included in the heatmap. Sample 








Figure 3.9 – Detection of a single PC3 cell in 29 HeLa cells (principal components 
analysis). 
PCA/PAM clusters the single PC3 cell in 29 HeLa cells (n = 8) together with single PC3 cells in isolation 
(n = 8) by the 161 gene isoform signature (A, k = 2) but not by all detectable gene isoforms with 
detectable expression (B, k = 5). In Figure B, reads mapped to 112,845 gene isoforms out of a total of 
149,135 (76%) across all samples. PAM cluster analysis distinguished PC3 cells from HeLa cells in all 
principal component analyses (A and B). Single PC3 cells did not cluster in a single cluster when all 
gene isoforms with detectable expression were analysed. Ellipses assume a multivariate normal 
distribution with the confidence level set at 95%.  
 






We were also able to distinguish single PC3 cells from the 29 HeLa cell background by 
PCA of both the 161 gene isoform signature (Figure 3.9A) and global transcript 
expression levels (Figure 3.9B). PCA/PAM clustering of the 161 gene isoform signature 
showed that single PC3 cells in the 29 HeLa mix and single PC3 cells in isolation 
clustered together. PCA/PAM clustering of the global transcript levels showed that 
single PC3 cells in a 29 HeLa background could still be distinguished from 30 HeLa cell 
















3.3.2 Detection of a single LNCaP cell in 29 HeLa cells 
The volcano plots in Figure 3.10 illustrate the number of differentially expressed gene 
isoforms in LNCaP cells relative to HeLa cells. We detected a single LNCaP cell in 29 
HeLa cells by 64 gene isoforms that were over expressed in both volcano plots A and B 
depicted in Figure 3.10. The PSA gene was highlighted due to its biological and clinical 
relevance in prostate cancer. PSA was over-expressed in 30 LNCaP cells relative to 30 
HeLa cells (volcano plot A: log2 fold change = 6.4, P < 0.01). The MAGED1 gene was 
also over expressed in 30 LNCaP cells relative to 30 HeLa cells (volcano plot A: log2 fold 
change = 7.1, P < 0.05). 
 
PSA was over-expressed in the single LNCaP cell in 29 HeLa cell background (volcano 
plot B: log2 fold change = 4.0, P < 0.05). MAGED1 was also over expressed in the single 
LNCaP in 29 HeLa cell background, but not to the same degree of statistical significance 
(volcano plot B: log2 fold change = 4.9, P < 0.1). MA plots for both volcano plots 
(Appendix 5.3, Figure 5.6) show slopes of the loess curves are around 1 (horizontal) at 
y axis = 0, indicating that there are no systemic biases requiring further normalisation 
(Cleveland et al., 2017). 
 
In the individual samples depicted in the heatmap in Figure 3.10, only 4 out of 8 of the 
single LNCaP cell in the 29 HeLa background samples exhibited PSA over-expression. 
PSA was over-expressed in 7 out of 8 single LNCaP cell samples. Three of the single 
LNCaP cell in 29 HeLa cell background samples (samples 5, 6 and 7) only showed over-
expression across 5 out of 64 gene isoforms in the heatmap. Sample 5 only showed 
weak over-expression in one gene isoform out of 64. No single gene isoform exhibited 
consistent over-expression in single PC3 cells that would enable detection in a HeLa 
background. 
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Figure 3.10 – Detection of a single LNCaP cell in 29 HeLa cells. 
Volcano plots of differentially expressed gene isoforms between 30 LNCaP (n = 3) and 30 HeLa cells (n 
= 4) (A), and a single LNCaP cell in 29 HeLa cells (n = 8) and 30 HeLa cells (n = 4) (B). The highly 
differentially expressed (log2 fold change >1), statistically significant (P < 0.05) gene isoforms 
(highlighted in red) that were shared between both volcano plots were analysed in a heatmap of 30 
HeLa cells, a single LNCaP cell in 29 HeLa cells and single PC3 cells alone (C). 64 gene isoforms 
identified the presence of a single LNCaP cell in 29 HeLa cells (P < 0.05). The PSA gene isoform was the 
most consistently over-expressed gene in LNCaP cells relative to HeLa cells. The 30 LNCaP cells were 
not included in the heatmap. Sample identifier numbers are in brackets along the x axis of the 
heatmap. 
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Figure 3.11 – Detection of a single LNCaP cell in 29 HeLa cells (principal components 
analysis). 
PCA/PAM clusters the single LNCaP cell in 29 HeLa cells (n = 8) together with single LNCaP cells in 
isolation (n = 8) by the 64 gene isoform signature (A, k = 3) but not with all detectable gene isoforms 
(B, k = 2). In Figure B, reads mapped to 115,239 gene isoforms out of a total of 149,135 (77%) across 
all samples. PAM cluster analysis could not distinguish 30 HeLa cells (n = 4) from samples with a single 
LNCaP cell in 29 Hela cells when all gene isoforms with detectable expression were analysed. Ellipses 
assume a multivariate normal distribution with the confidence level set at 95%.  
 






We were also able to distinguish single LNCaP cells from the 29 HeLa cell background 
by PCA of the 64 gene isoform signature (Figure 3.9A), but not global transcript 
expression levels (Figure 3.9B). PCA/PAM clustering of the 64 gene isoform signature 
showed that single LNCaP cells in the 29 HeLa mix and single LNCaP cells in isolation 
clustered together. PCA/PAM clustering of the global transcript levels showed that 
single PC3 cells in a 29 HeLa background could not be distinguished from 30 HeLa cell 
















3.3.3 Detection of a single PC3 cell in 199 LNCaP cells 
The volcano plots in Figure 3.12 illustrate the number of differentially expressed gene 
isoforms in PC3 cells relative to LNCaP cells. We detected a single PC3 cell in 199 LNCaP 
cells by 23 gene isoforms that were over expressed in both volcano plots A and B 
depicted in Figure 3.12. The gene isoform with the highest consistent over-expression 
in the 23 gene isoforms in the single PC3 in 199 LNCaP samples was ENTPD7 (Figure 
3.12B). ENTPD7 was over-expressed in both volcano plot A (log2 fold change = 3.5, P < 
0.05) and volcano plot B (log2 fold change = 2.7, P < 0.05). MA plots (Appendix 5.3, 
Figure 5.7) for both volcano plots show slopes of the loess curves are around 1 
(horizontal) at y axis = 0, indicating that there are no systemic biases requiring further 
normalisation (Cleveland et al., 2017). 
 
No single gene isoform had consistent over-expression in single PC3 cells relative to 
LNCaP cells. In the individual samples depicted in the heatmap in Figure 3.12, only 1 




Figure 3.12 – Detection of a single PC3 cell in 199 LNCaP cells. 
Volcano plots of differentially expressed gene isoforms between 30 PC3 (n = 3) and 30 LNCaP cells (n = 
4) (A), and a single PC3 cell in 199 LNCaP cells (n = 3) and 200 LNCaP cells (n = 3) (B). The highly 
differentially expressed (log2 fold change >1), statistically significant (P < 0.05) gene isoforms 
(highlighted in red) that were shared between both volcano plots were analysed in a heatmap of 200 
LNCaP cells, a single PC3 cell in 199 LNCaP cells and single PC3 cells alone (C). 23 gene isoforms 
identified the presence of a single PC3 cell in 199 LNCaP cells (P < 0.05). The ENTPD7 gene isoform was 
the most consistently over-expressed gene in single PC3 in 199 LNCaP cell samples relative to LNCaP 
cells alone. The 30 PC3 cells and 30 LNCaP cells were not included in the heatmap. Sample identifier 
numbers are in brackets along the x axis of the heatmap. 
 








Figure 3.13 – Detection of a single PC3 cell in 199 LNCaP cells (Principal Components 
Analysis). 
PCA/PAM of samples distinguishes the single PC3 cell in 199 LNCaP cells (n = 3) from 200 LNCaP cells 
(n = 3) with both the PC3 23 gene isoform signature (A, k = 2) all gene isoforms (B, k = 3). In Figure B, 
reads mapped to 88,083 gene isoforms out of a total of 149,135 (59%) across all samples. Ellipses only 
serve to highlight clusters and do not represent a multivariate normal distribution.  
 






We could also distinguish single PC3 cells from the 199 LNCaP cell background by PCA 
of both the global transcript levels (Figure 3.13B) and the 23 gene isoforms identified 
in Figure 3.12 (Figure 3.13A). The single PC3 cells in 199 LNCaP cells grouped in a single 
cluster according to the expression of all detectable gene isoforms (59% of gene 






Single PC3 cells in isolation clustered separately from single PC3 cells in 199 LNCaP cells 
in both the 23 gene isoforms and global transcript levels in the PCA/PAM analysis 
(Appendix 5.2, Figure 5.3). There were too few points to calculate an uncertainty 







3.3.2 qPCR validation of RNA-seq for single cell detection 
Our RNA-seq results from detecting single cells in a milieu identified high expression of 
the MAGED1 gene in 30 PC3 cells and single PC3 cells in 29 HeLa cells (Figure 3.8) 
compared to LNCaP cells (Figure 3.10). These RNA-seq results also identified PSA gene 
expression in LNCaP cells (Figure 3.10) but no detectable expression in PC3 cells. We 
validated the RNA-seq results for the expression of these specific genes with 
quantitative PCR (Figure 3.14).  
 
Figures 3.14A and B illustrate PSA and MAGED1 gene expression patterns in bulk tissue 
samples correspond with the pattern of gene expression from RNA-seq in bulk tissue 
samples (Figures 3.14C and D) and single cell samples (Figures 3.14E and F). 
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Figure 3.14 – qPCR of MAGED1 and PSA. 
Gene expression analysis of the MAGED1 and PSA genes in LNCaP and PC3 cell tissues from 
quantitative PCR analysis of bulk cells from 100ng of RNA (A and B, triplicate samples for both cell 
lines) compared with RNA-seq gene expression data from 30 cells (C and D, triplicate samples for both 
cell lines) and single cells (E and F, eight samples for each cell line). Red data points are individual 
samples. Differences in expression between tissues for both genes were statistically significant (* = 
P>0.05, ** = P>0.1). 
 
















Single cell analysis technologies have undergone rapid progress in recent years in terms of 
numbers of processed cells. Despite this, lower throughput well based single cell 
technologies continue to contribute to the single cell analysis literature (Choi and Kim, 
2019). These plate based methods tend to produce higher quality libraries for a lower 
overall cost, one of the main reasons for their continued use. It is also generally more 
efficient to capture rare cell types with known cell-surface markers using flow-sorting and 
preparing plates of single cell libraries rather than to capture more cells using a high 
throughput droplet based method (Griffiths et al., 2018). In experiments that prioritise the 
quality of single cell libraries over the quantity of cells, low throughput plate based methods 
are still preferred. 
 
This thesis considered troubleshooting strategies for a method capable of analyzing ultra-
low input RNA, including a relevant portion of a single cell transcriptome (Day et al., 2018). 
The method is based on using PCR to pre-amplify the mRNA population, and subsequently 
using IVT linear amplification to produce a library amenable to analysis using the Illumina 
MiSeq instrument. We applied this method to analyse the single cell transcriptomes from 
the PC3 and LNCaP cell cultures.  
 
The PC3 and LNCaP prostate cancer lines also have single cell transcriptome data publicly 
available from the PCR based study of Ramsköld et al., (2012), one of the most highly cited 
papers in the single cell field. We did a comparative analysis of our results with Ramsköld et 
al., (2012). The comparison buttressed our results for distinguishing single cells from the two 
prostate cancer cell lines. It also sheds some light on how well single cell transcriptomes 
replicate across studies.  
 
We also applied this method to detect mRNA transcripts from a PC3 or LNCaP single cell that 
was mixed in background cells of a different type. This approach to isolating a single cell’s 
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breadth of gene expression in a deferential background population is novel in the literature. 
This application has possible implications for a diagnostic test or identifying a rare sub-
population with prognostic relevance in a tumour.  
 
4.1 cDNA amplification methodology design 
We utilized an oligo-dT that latches on to the poly-A tail of mRNA (Figure 1.6, Figure 2.1). 
This oligo-dT incorporates PCR and IVT primers, in addition to a unique barcode that allows 
pooling of samples for more efficient amplification (Figure 2.4). This allowed us to use a PCR 
amplification step (exponential amplification; mRNA to cDNA), followed by a T7 RNA 
polymerase driven IVT step of pooled single cell samples (linear amplification; cDNA to 
aRNA).  
 
The combination of PCR and IVT remains rarely reported in single cell studies. Kurimoto et 
al. (2006) and Suslov et al. (2015) have pursued this approach. They both carried out a PCR 
‘pre-amplification’, followed by a T7 RNA polymerase driven IVT. Both studies have serious 
shortcomings regarding transcriptome wide analysis. Suslov et al.’s analysis of single cells 
was limited to 44 genes from a microarray. The Kurimoto study claims to have produced a 
microarray approach, despite not presenting any data in this regard. 
 
There are several advantages to utilising PCR followed by IVT in the context of single cell 
transcriptome analysis. The preliminary PCR step creates double stranded cDNA, which is a 
prerequisite for T7 RNA polymerase activity. In our method, the primary intention of IVT is to 
simplify gene expression data analysis by converting the full length reads to 3’ end only.  T7 
polymerase amplifies from the 3' end and is limited to amplifying between 200 and up to 
4000bp (Bolon and Graham 2011; Skinner et al., 2004). A 3' enriched library makes it 
unnecessary to normalise gene expression to gene length. 
 
We found that reads unexpectedly aligned to regions far beyond the poly-A tail 3’ end of 
mRNA, including intronic regions potentially in precursor mRNA (Appendix 5.4, Figure 5.8). 
We hypothesise that this could be due to internal poly Adenine sequences. Nam et al. (2002) 
show that even anchored Oligo-dT potentially had a 51% rate of internal poly-A priming 
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Figure 4.1 – Internal poly-A priming by the oligo-T primer 
The oligo-dT can prime poly-A sequences present internally within mature mRNA or inside 
intronic regions in precursor mRNA in addition to the poly-A tail. The initiation of cDNA 
synthesis from both locations can result in two truncated cDNAs from a single mRNA template 
(Nam et al., 2002). 
	
 
(Figure 4.1). We show that the clear majority of our transcripts were limited to the 3’ end 
(Figure 3.6).  
 
Oligo-dT priming remains a conventional method for isolating mRNA in single cell RNA-seq 
studies. This is primarily because depletion of rRNA and tRNA is not possible at the single-






Another advantage of the PCR/IVT approach is that single cell samples can be pooled after 
PCR amplification because of a unique barcode incorporated into the oligo-dT (Islam et al., 
2011). We used this approach to pool barcoded double stranded cDNA samples for a much 
larger starting amount that can be further amplified by IVT linear amplification by the T7 
RNA polymerase. This results in the production of several milligrams of aRNA, utilizing less 
T7 polymerase than would be the case without a PCR pre-amplification. 
 
4.2 Optimisation of the cDNA library amplification methodology 
The first obstacle to producing a quality cDNA library was to resolve artifacts that may vitiate 
the quality of the single cell RNA-seq data. The most prominent artifact was a ‘hedgehog’ 
like pattern (Figure 3.1A, C). This pattern was also observed by Picelli et al. (2014) (Figure 
4.3). Picelli et al. suggested that this pattern is due to ‘concatamers’. Concatamers occur 
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Figure 4.2 – cDNA concatenation with TSO 
Model of cDNA synthesis that occurs with a TSO that lacks a biotin molecule attached to the 5’ 
end of the TSO.  
	
 
Figure 4.3 – cDNA library optimisation electropherograms 
Representative examples from Picelli et al., (2014) of the cDNA distributions from a successful 
cDNA library pre-amplification of a single mouse embryonic fibroblast cell (A) and from a 
‘hedgehog’ pattern cDNA library pre-amplification of a single human T cell (B).  
	
 
RTase reaction fails to terminate; the MMLV RTase continues to reverse transcribe the TSO 
as if it were a continuation of the mRNA (Figure 4.2). This process of concatenation produces 





We resolve this hedgehog pattern by attaching a biotin molecule to the 5’ end of the TSO 
which is able to terminate the MMLV RTase reaction (Figure 1B, D). Biotin modified 
oligonucleotides are commonly used to purify target nucleotides with streptavidin beads 
that bind biotin. The use of a biotin attached to the 5’ end of the TSO shows that the cause 






Another issue was determining the optimal RTase enzyme for single cell cDNA library 
production. We found that the Kapa HiFi HotStart DNA polymerase produced the cDNA 
library electropherogralm pattern that most resembled a good quality library compared to 
Kapa 2G Robust DNA polymerase (Figure 3.2). Kapa HiFi HotStart has been found to 
introduce the least bias in sequencing amplified bacterial genomes when compared to 
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unamplified samples (Quail et al., 2012). The electropherograms shown in Figure 3.2 are 
representative examples of the cDNA libraries produced by both polymerases.  
 
4.3 Single cell statistical analysis 
There are a variety of algorithms that can be used to statistically analyse a data set, each 
producing wildly varying results and conclusions. Therefore, the use of an algorithm requires 
robust justification in the context of the technical and biological parameters that produced 
the data. We used principal components analysis (PCA) for the study of single cell 
transcriptomes, a common statistical technique in the single cell literature (Lall et al., 2018).  
 
PCA illustrated the similarities and differences between samples in a simple visualization 
(Figures 3.5, 3.9, 3.11 and 3.13). Most variation in samples is generally captured in the first 
two principal components (McVean, 2009). This technique is particularly powerful for 
simplifying the variation across datasets with thousands of genetic variables and identifying 
structure caused by diverse processes. We used partitioning around the mediods (PAM) to 
cluster samples with substantially similar gene expression profiles according to the first two 
principal components.  
 
PAM is the most common technique in k-medoids clustering (Teschendorff and Enver, 
2017). A medoid is a centrally located point in a cluster whose average dissimilarity to all the 
objects in a cluster is minimal. PAM finds clusters by using a pre-defined number of clusters 
(k) as an a priori input. Our PCA figures show clustering results after running PAM with 
different choices of k, the number of clusters. The input number of clusters was chosen 
based on the result that most closely resembled the number of expected clusters in the 
data.  
 
PAM and the k-medoids technique was chosen because it is more robust than the 
alternative k-means technique (Kaufman and Rousseeuw, 1987). This is because it is less 
susceptible to noise and outliers, a significant factor in single cell studies. 
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4.4 Normalisation of single cell data 
There are several crucial design factors to consider in a single cell RNA-seq analysis 
experiment. These factors allow us to achieve the primary objective of our single cell 
analysis: to distinguish individual cells based on their distinctive biology, rather than by 
technical noise inherent in a methodology. The major factors can be summarized as follows 
(Conesa et al., 2016): 
1) Technical biases; 
2) Biological biases; and 
3) Read depth. 
Addressing these factors allows us to potentially identify novel sub-populations. Dissecting 
biological and technical bias has been the foremost issue in single cell analyses. The priority 
is in developing a method capable distinguishing biologically or clinically relevant 
information in populations of single cell. This means developing a laboratory method with 
low technical variation. It also means employing sound computational methods to normalize 
single cell data sets for technical and biological confounding factors.  
 
The type of normalization depends on the objective of the experiments. Our objective was 
to distinguish single cell types, including single cells seeded in a population of a different cell 
type. This means we must normalize for technical factors and biological factors that do not 
depend on cell type. This may include cell cycle effects and library size. 
4.4.1 Technical biases 
Libraries from single cells from PC3 and LNCaP cell lines were generated in two separate 
experiments and eight single cells from each cell type were run on different Illumina MiSeq 
sequencing runs. Technical variation can occur within an experiment and can be accounted 
for with technical replicates from a single biological source, like a single tissue sample or cell 
line. This is obviously not possible with an idiosyncratic single cell. The closest technical 
replicate we can come to in single cell studies is individually processing single cells from the 
same population source through separate parallel experiments.  
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Ramsköld et al. (2012), processed four single cells from both the LNCaP and PC3 cell lines 
through individual experiments with the Genome Analyser IIx sequencing platform 
(Illumina). These pseudo-technical replicates permitted an accounting of technical variation 
across and within experiments. Ramsköld et al. assessed technical variation by comparing 
the Pearson correlations between single cells with diluted mRNA replicate samples 
equivalent to single cell amounts (10pg). They found higher intra-Pearson correlations 
between single cells of the same type (0.75-0.85) compared with 10 pg dilution replicates 
(0.65-0.75).  
 
They also compared diluted 10 pg samples with unamplified 100 ng samples from the same 
source. The scatter plot Pearson correlation between the 10pg and unamplified 100ng 
samples was 0.58. This analysis identified two populations of low abundance transcripts 
with distorted expression, which according to Ramsköld et al. represented stochastic 
technical losses. Despite this loss, they found that most low expressed genes could be 
reliably detected. A microarray experiment on picogram amounts of mRNA also found the 
transcriptome skewed towards high abundance transcripts, but the overall transcriptome 
was preserved (Kurimoto et al., 2006). Ramsköld et al. concluded on this basis that relative 
gene expression levels were not significantly disrupted by technical variation. 
 
However, there are two major problems with Ramsköld et al.’s analysis regarding their 
Pearson correlations. Firstly, they use logarithmic values to calculate correlations. 
Correlations between logarithmic values will always be artificially higher than correlations 
between raw values. The true Pearson correlation for Ramsköld et al.’s single cells is 
reflected in Figures 3.4B and 3.4C. Our analysis reveals real Pearson correlations for 
Ramsköld et al.’s PC3 single cells are significantly lower than reported by Ramsköld et al. 
(2012). In contrast, the Pearson correlations between single Ramsköld LNCaP cells is 
relatively high (0.91-0.94). 
 
Secondly, it is not clear if the poor Pearson correlation for Ramsköld et al.’s PC3 cells is due 
to technical or biological variation. This is an inherent problem with using Pearson 
correlations to make conclusions about technical variation. If Pearson correlations are high, 
this is a good indication that there is low technical and biological variation. This is the case 
 75 
with our single cell data, where we have consistently high Pearson correlations across single 
cells of the same type (Figure 3.4A). However, a low Pearson correlation does not 
differentiate between biological and technical variation per se.   
 
The Ramsköld et al. PC3 sample with the poorest Pearson correlations is Sample 2 (Figure 
3.4A, Pearson correlation range = 0.12-0.47) has a similar gene detection profile compared 
to the other PC3 single cells (Appendix 5.5, Table 5.1; Sample 2 = 68.7% genes detected; PC3 
mean = 70.3% genes detected, n = 4) with a similar number of reads (Appendix 5.5, Table 
5.1; Sample 2 = 22.8 million reads; PC3 mean = 23.2 million reads, n = 4). Interestingly, PC3 
sample 2 still clusters with the other PC3 cells based on the first two principal components, 
while maintaining an exclusive 95% confidence ellipse vis-à-vis the LNCaP cluster (Appendix 
5.2, Figure 5.4). PC3 sample 2 is mostly distinguished from the other PC3 single cell samples 
by the second principal component, accounting for only 32% of the variance. 
 
The PCA demonstrates that despite the low correlation with other PC3 cells, PC3 sample 2 
still maintains a PC3 principal component signature. This is a possible indication that the 
variation might be predominantly attributed to biology, rather than a technical fault. 
Technical variation would likely lead to loss of gene expression characteristic of PC3 cells. In 
contrast, Biological variation unrelated to cell type would still retain some gene expression 
characteristic of PC3 cells. Further data analysis is required to confirm that this anomalous 
sample’s gene expression behaviour is due biological processes such as variations in cell 
cycle. 
 
Chapman et al. (2015) suggest that using transcriptome wide correlation is a poor metric for 
technical reproducibility in single cells. They studied correlation between two replicates of 
single cell equivalent amounts derived from a pool of 100 cells and found that highly 
expressed genes largely determined the correlations. The top 1% most highly expressed 
genes accounted for 15% of the correlation. This is a challenge for single cell methods in that 
the clear majority of genes are expressed at the 1 – 30 transcript range, including many 
essential RNAs (Zenklusen et al., 2008). 
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If the overall variability of single cell gene expression is skewed towards highly expressed 
genes this means that subtle, yet potentially clinically relevant information is being missed 
or distorted by studying variability at a transcriptome level. High Pearson correlations are a 
crude indication of low biological variability that is clinically meaningful. However, high 
correlations can still give a good indication of low technical variability. We can therefore 
state that there is probably a relatively low degree of technical variability from the high 
Pearson correlations across our single cells (Figures 3.4A and 3.4C). 
4.4.2 Biological biases 
Cell cycle has been confounding factor in distinguishing cell types in single cell transcriptome 
studies (Barron and Li, 2016). A significant proportion of the transcriptome is determined by 
cell cycle stage. Dominguez et al. (2016) identified 1182 genes with cell cycle dependent 
expression in HeLa cells. Gene expression between single cells can vary simply because of 
the stage at which they are sampled in the cell cycle, complicating attempts to understand 
biological variation between individual cells. 
 
In addition to periodic gene expression, the cell cycle gene profile is different for different 
cell types. Breast tumours are notable for the range of ‘mitotic traits’ that correlate with 
prognosis, whereas kidney tumours have a homogenous cell cycle profile (Dominguez et al., 
2016). Despite this heterogeneity in cell cycle, Dominguez et al. (2016) identified a core set 
of 67 cell cycle genes that have highly periodic expression in common with five diverse cell 
lines. Elevated expression of these genes is associated with aggressive breast, lung and 
ovarian cancers. 
 
The heterogeneity in cell cycle genes across cell types is a major complicating factor in 
efforts to normalise single cells for cell cycle (Buettner et al. 2015; McDavid et al., 2016). 
This is especially so when the cell cycle genes for the tissue under study are unknown. This is 
the case for PC3 and LNCaP cells. 
 
While cell cycle can potentially confound clustering of different single cell types, the degree 
to which cell cycle masks true physiological differences between single cells is a matter of 
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debate in the literature. Buettner et al.’s (2015) computational analysis was the first attempt 
to determine the degree to which cell cycle is responsible for single cell variability.  
 
Buettner et al. estimated the proportion of variance attributable to a latent variable by 
inferring a cell-to-cell covariance matrix from the gene expression profile of 892 cell cycle 
genes. They determined that cell cycle accounted for more than 30% of the variation 
between 81 single T helper 2 cells.  
 
McDavid et al. (2016) disputed the effect of cell cycle genes by citing their own analysis of 
single cells. They found that cell cycle only accounted for 17% of the variance in cell cycle 
genes and 5% in non-cell cycle genes. McDavid studied 119 cell cycle genes that passed their 
quality control from 930 cells across three cell lines. 
 
McDavid et al. also re-analysed Buettner et al.’s data and explored other factors that could 
be responsible for the observed variation between single cells. They found that the first 
principal component correlated strongly (R2>0.99) with library size. McDavid et al. argue that 
Buettner et al.’s latent variable is actually quantifying the variance attributable to library size, 
rather than cell cycle per se. Library size distinguishes cell cycle in Buettner et al.’s data just 
as well as the first principal component. This may be because cell size and RNA library size 
correlate with cell cycle (Padovan-Merhar et al., 2015). 
 
McDavid et al. points out that a cell cycle effect remains even after correcting for the 
Buettner et al.’s latent variable. However, the variance in cell cycle corrected data for 
Buettner et al.’s T cells was still dominated by T cell differentiation, rather than cell cycle. 
McDavid et al. calculated the sums of squares to find the real variance attributable to cell 
cycle in Buettner et al.’s mESC data is actually less than 7%. 
 
To further complicate matters, Buettner et al. show that 44% of all genes studied (n=2881) 
showed significant correlation with at least one cell-cycle gene (P < 0.05), Bonferroni 
adjusted). This means that simply removing the suite of cell cycle genes before further 
analysis is insufficient for removing the cell cycle effect. This has led to the development of 
several Bayesian unsupervised clustering techniques to remove cell cycle effects (Lee et al. 
 78 
Figure 4.4 – Variance decomposition of single T helper 2 cells 
Estimated contributions of cell cycle to variance between single T helper 2 cells after 
normalisation of library size (Buettner et al., 2015). 
 
2018). Some of these techniques incorporate library size as a known factor for 
normalisation. 
 
Buettner et al.’s and McDavid et al.’s debates show that the contribution of cell cycle to 
overall cell-to-cell variance can vary greatly between cell types as well as different methods 
of analysis. This means that it is problematic to use a conventional set of cell cycle genes for 
defining the cell cycle effect across cell types.  
 
An alternative method of correcting for cell cycle might be to correct for library size, a 
substantiated covariate. Buettner et al.’s analysis shows that the contribution of cell cycle to 
overall variance is reduced from 30% to 5% or less when the data has been normalised for 





Buettner et al. normalised for library size by the method described in Brennecke et al. 
(2013). Brennecke et al. calculated two normalisation constants, one each for technical and 
biological variation. Dividing the read counts by these constants brought them on to a 
common scale that allows comparison across samples. The technical normalisation constant 
accounted for differences in read depth. The biological normalisation constant was 
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calculated with the variation in starting RNA in each single cell. Brennecke et al. extrapolated 
the starting RNA amount in single cell samples from the read counts that mapped to the 
reference genome and assumed a linear relationship between starting RNA amount and the 
proportion of mapped reads.  
 
We normalised our data for library size by scaling up sample total read counts to the single 
cell sample with the highest total read count. Obviously, this adjustment alone does not 
correct for cell cycle variability. In addition to this size correction, we used an empirical 
Bayesian method to conduct differential gene expression analysis to detect single cells in a 
background population. This was done with the Limma package in the R statistical platform 
(Phipson et al., 2016). Our empirical Bayesian approach leverages information from the 
entire dataset when making inference about each individual gene. This mitigates variances 
within samples of the same condition.  
 
Phipson et al. (2016) use an empirical Bayesian approach to shrink the estimated sample 
variances for each gene towards a pooled estimate. This is accomplished by fitting a 
separate t-distribution for each gene across samples in the same condition. Extra degrees of 
freedom are added to reflect the information borrowed from global gene expression 
behaviour for inference about each individual gene.  
 
In a classical Bayesian approach, prior external information is used to inform the predictive 
model. For example, this prior might be knowledge of the influence of cell cycle on variance. 
However, in this empirical Bayesian method, the prior information is informed by the 
marginal distribution of the data itself.  
 
For example, single cells with less starting RNA content consistent with the early S phase in 
the cell cycle will tend to have more variable read count data in the final library (Ramsköld et 
al., 2012). This may be due to technical limits in sensitivity, or elevated biological 
stochasticity in smaller cells. This systemic variation will be reflected in that sample’s 
marginal distribution. The Limma R package incorporates this information into the linear 
model fitted to each gene across all samples within each condition.  
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We suggest that this empirical Bayes approach to differential expression analysis mitigates 
the effect of cell cycle on variance across samples. This is supported by the absence of a bias 
trend in the loess fit in MA plots related to average gene expression plotted against 
differential expression to identify single cells in a background population (Appendix 5.3, 
Figures 5.5, 5.6, and 5.7).  
 
In the gene signatures that differentiate a single cell from a background population, none of 
the single cell genes are part of the core 67 cell cycle genes (Appendix 5.5, Table A3). 
However, there remains significant variability in our ability to distinguish single cells in a 
background. For example, in the 64 gene isoform signature for detecting a single LNCaP cell 
in 29 HeLa cells, sample 5 only had one gene isoform showing elevated expression indicative 
of a single LNCaP cell (Figure 3.10). This may be due stochastic biological and technical 
factors, rather than systemic biases such as cell cycle. 
 
As noted, cell cycle effects are not isolated to cell cycle genes because of gene-to-gene 
interactions (Buettner et al., 2015). Also, the core 67 cell cycle genes may not be relevant to 
LNCaP or PC3 cells. The absence of core 67 cell cycle genes is only an indication that cell 
cycle variation is not a major confounding factor in the single cell gene expression signature. 
 
The weak LNCaP signature in LNCaP sample 5 might be due to technical variation, or the 
influence of cell cycle variance that has not been completely mitigated by the empirical 
Bayesian method. Further analysis is required to comprehensively measure the latent 
variability due to cell cycle in LNCaP and PC3 single cells, perhaps by unsupervised gene 
clustering analysis.  
4.4.3 Read depth 
An appropriate read depth for single cell studies has been thoroughly discussed in the 
literature and it is generally considered that less than a million reads is acceptable (Ramsköld 
et al., 2012). It has been demonstrated that 20,000 reads per cell is sufficient to distinguish 
different cell types in the same splenic tissue (Jaitin et al., 2014). Our lowest number of 
reads for a single cell was 23,462 (Appendix 5.5, Table 5.2) but this was sufficient for 
distinguishing cell type (Figure 3.5).  
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Deeper sequencing, such as attempted by Ramskold et al. (2014) with over 20 million reads 
per cell, does little to resolve differences between single cells. This is because single cells 
contain a tiny number of individual mRNA molecules (100-300,000 transcripts) and only a 
small proportion are reverse-transcribed to cDNA for analysis (Jaitin et al., 2014; Marinov et 
al., 2014). A possible advantage of having such extreme saturation of reads is the fine 
discrimination of allele specific expression. 
 
Raw read counts can be converted to ‘reads per kilobase million’ (RPKM), ‘fragments per 
kilobase million’ (FPKM) or ‘transcripts per million’ (TPM). These units remove the bias of 
different gene lengths within samples and variability in sequencing depth between samples. 
In our experiments, normalising for read depth is particularly important because our single 
cell samples vary considerably in the sum of reads in the final library for analysis (LNCaP 
single cell read sum sample range = 24,102 – 374,678; PC3 single cell read sum sample range 
= 23,462 – 145,815; Appendix 5.5, Table 5.2).  
 
It has been a common approach in the literature to normalise different read counts across 
samples by RPKM or FPKM. Ramsköld et al. (2012) use RPKM in their analysis of single PC3 
and LNCaP cells to account for variability in gene length. We used the same unit for their 
data in our analysis for the sake of comparability with their conclusions.  
 
The major flaw of using RPKM or FPKM units in the place of raw read counts is that the 
presence of highly expressed genes in a sample can disproportionately alter RPKM and 
FPKM values. That is because RPKM and FPKM are calculated in a way that results in 
different sums of reads across samples. FPKM and RPKM use different proportionality 
constants for each sample because the proportion of reads tend to be different across 
samples in different conditions. This makes the comparison of gene expression between 
samples using RPKM or FPKM flawed. 
 
It is more appropriate to use TPM when comparing samples across different experimental 
conditions (e.g. different cell types, or different RNA-seq runs) because it uses a universal 
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constant. The sums of raw read counts for each sample across all conditions are divided by 
the same number (i.e. ‘per million’, the universal constant), producing a scaling factor for 
each sample. Read counts for each gene can be divided by this scaling factor, enabling direct 
comparison of relative gene expression across conditions.   
 
In our single cell data, we found scaling up read counts in each sample to the sample with 
the highest read depth sufficient to normalise for read depth. This is illustrated in 
overlapping sample profiles in the cumulative distribution plot (Appendix 5.7, Figure 5.9). 
This plot demonstrates that single cell samples were well normalized for comparison. 
Normalisation is also confirmed by loess profiles in MA plots for the bulk samples (see 
Appendix 5.3, Figures 5.6 - 5.7). 
 
The MA and cumulative distribution plots also show no significant bias from gene length. 
This is because our method predominantly quantified reads from the 3’ end of mRNA 
transcripts (Figure 3.6). This meant that normalisation for gene length was not required, 
avoiding the need for a scaling factor. 
 
4.5 Sensitivity and fidelity 
Dissecting biological and technical bias has been the foremost issue in single cell analyses. 
The priority is in developing a method capable distinguishing biologically or clinically 
relevant information in populations of single cell. This requires a method with good 
sensitivity and fidelity of mRNA detection.  
 
Sensitivity refers to a method’s ability to capture and convert a specific mRNA molecule to a 
cDNA read in the final library analysis. The method must be able to capture a biologically 
meaningful number of mRNA molecules that are distributed across genes in an amount 
reflective of the actual gene expression.  
 
We compared our single cell transcriptomes with single cell transcriptome data produced by 
a PCR based method developed by Ramsköld et al. (2012). We calculated the number of 
genes detected per read in the Illumina MiSeq libraries. The number of genes detected per 
 83 
read informs us how many genes we can detect with a given number of reads. This gives an 
indication of the sensitivity of detection for gene expression.  
 
Ramsköld et al. over-sequenced samples to detect as many genes as they could by using one 
cell in a single Illumina MiSeq run (~25 million reads per sample), whereas we multiplexed 
multiple single cells in a single run. We determined that our method detected vastly more 
genes per transcript compared to Ramsköld et al. (Figure 3.3). However, this was due to 
Ramsköld et al. using the maximum number of reads for a single cell and our protocol 
avoiding over-sequencing of longer genes by enriching for the 3’ end. This comparison still 
provides a reference point indicating that our method has good sensitivity. Our method 
detected up to a third of the genes in single cells with only 0.005% of the reads used on 
average by Ramsköld et al., while enabling us to clearly distinguish single cell types (Figure 
3.5; Appendix 5.5, Table 5.2).  
 
This thesis did not comprehensively evaluate the sensitivity of the methods. This would 
require a spike in of pre-determined amounts of artificial mRNA molecules into the sample 
prior to amplification. For example, ERCC spike ins are 92 poly-adenylated transcripts with a 
wide range of lengths and GC contents that mimic natural eukaryotic RNA (Jiang et al., 
2011). They are aliquoted in predetermined amounts with RNA samples under study and act 
as an external standard by which to measure the ability of a method to capture the 
endogenous mRNA.  
 
Day et al. (2018) used ERCC spike ins to evaluate the sensitivity of the thesis method. They 
demonstrate that our method can detect approximately 48% of input mRNA molecules from 
a single cell. Islam et al. (2014) also found an average capture efficiency of 48%. Islam et al. 
also used a TSO based PCR method but included his multiplex barcode in the TSO. We 
included our multiplex barcode in the oligo-dT rather than the TSO to reduce the TSO’s 
length. A shorter TSO has been shown to improve mRNA capture efficiency (Zajac et al., 
2013). 
 
We did not evaluate the fidelity of the methods. A method with good fidelity produces a 
result that is consistent with the original distribution of reads across the transcriptome, so 
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that the detection of expression from one gene isn’t disproportionately represented in the 
final analysis. This may be particularly relevant to PCR based exponential amplification 
methods, where small initial biases can quickly escalate. One way to better ensure that the 
final library is faithful to the original transcriptome is to use unique molecular identifiers that 
attach to each mRNA molecule before amplification (Islam et al., 2014). 
 
Several normalization methods have also been developed to correct for the artificially 
unequal distribution of sequencing reads. For example, two-parameter generialized Poisson 
models have been developed that simultaneously consider read depth and sequencing bias 
as independent parameters (Srivastava and Chen, 2010). More complex Bayesian 
normalization methods have been developed to detect and account for hidden gene 
expression determinants across multiple samples (Stegle et al., 2012; Mostafavi et al., 2013). 
Further study could employ these techniques to evaluate amplification fidelity in our 
method.  
 
4.6 Detection of a single cell in a background population 
We detected a single cell gene expression signature for either single PC3 or LNCaP cells in a 
background population ranging from 30 cells to 200 cells. This was done across three 
separate sequencing runs on the Illumina MiSeq platform:  
i. Detecting single PC3 cells in a background population consisting of 29 HeLa cells; 
ii. Detecting single LNCaP cells them in a background population consisting of 29 HeLa 
cells; and 
iii. Detecting single PC3 cells in a background population consisting of 199 LNCaP cells. 
The detection of single cell gene expression signatures illustrates the potential of the 
method to detect rare cell types in a tissue. We selected a HeLa population background 
because they have a very different genetic origin and profile compared to prostatic cancer 
cell lines. This increased the chance of success of our proof of principle experiments. HeLa 
cells are also readily available and easy to culture.  
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PC3 cultures have a modal chromosome number at 62 and LNCaP cultures range from 76 to 
91 chromosomes (Ohnuki et al., 1980; Chu et al., 1983). HeLa cells have 76 to 80 heavily 
mutated chromosomes, with catastrophic chromothripsis across several chromosomes 
(Landry et al., 2013). Chromothripsis is a phenomenon involving karyotype level random 
chromosome shattering and rearrangement. This occurs in 2-3% of all cancers. PC3 and 
LNCaP cultures in contrast have much more localised rearrangements (Wu et al., 2012).  
4.6.1 Detection of a single PC3 cell in 29 HeLa cells 
Our method could identify single cells in all three background population experiments. We 
show significant gene expression variability within the signature across single cell samples 
(Figures 3.8, 3.10 and 3.12). Due to the ability of empirical Bayes to smooth out systemic 
bias we suggest that this variability is due to stochasticity in technical and biological 
variation, rather than say cell cycle. This is supported by the lack of core 67 cell cycle genes 
in the distinguishing gene signature (Appendix 5.6, Table 5.3). 
 
We discovered a 161-gene isoform signature distinguished a single PC3 cell from a 29 HeLa 
cell background (Figure 3.8). The single PC3 cells in a HeLa background cluster with single 
PC3 cells in isolation based on this 161-gene isoform signature in the PCA (Figure 3.9A). 
Single PC3 cell in a HeLa background samples clustered separately from 30 HeLa cell samples 
according to the whole transcriptome PCA (Figure 3.9B). This demonstrates that our method 
(Figure 3.7) can distinguish PC3 single cells in a background based on the whole 
transcriptome and identify the PC3 gene expression of the single cell.  
4.6.2 Detection of a single LNCaP cell in 29 HeLa cells 
We identified a 64-gene isoform signature distinguished a single LNCaP cell from a 29 HeLa 
cell background (Figure 3.10). According to PCA, the ‘single LNCaP cells in a HeLa 
background’ cluster with single LNCaP cells in isolation based on this 64-gene isoform 
signature (Figure 3.9A). Single LNCaP cell in a HeLa background samples clustered with 30 
HeLa cell samples relative to single LNCaP cells in isolation according to the whole 
transcriptome PCA (Figure 3.9B).  
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This result demonstrates that our method (Figure 3.7) can distinguish LNCaP single cells in a 
background based on the LNCaP signature. However, the ‘single LNCaP cell in HeLa 
background’ samples were not able to be distinguished from 30 HeLa cells according to the 
whole transcriptome. This might be because the single LNCaP cells have lower gene 
detection per read than the single PC3 cells (Figure 3.3), indicating lower sensitivity in gene 
detection in the LNCaP cell sequencing run than the PC3 cell sequencing run. 
4.6.3 Detection of a single PC3 cell in 199 LNCaP cells 
In our third experiment, we went further by increasing the size of the background 
population to 199 cells to determine the sensitivity of single cell detection. We also used a 
prostate cancer cell line as a background population (LNCaP) rather than HeLa cells to try to 
identify a single cell from another prostate cancer culture (PC3).  
 
We successfully isolated a 23 gene isoform signature that identified a single PC3 cell in a 199 
LNCaP cell background (Figure 3.12). We could also distinguish single PC3 cells from the 199 
LNCaP cell background by PCA of both the global transcript levels (Figure 3.13B) and the 23 
gene isoforms identified in Figure 3.12 (Figure 3.13A). This illustrates the potential of our 
method to identify rare cell types in a tissue or tumour. However, the bootstrap value for the 
node separating the single cell in 199 LNCaP cells from 200 LNCaP cells was 30 
(approximately unbiased p-value = 97, Appendix 5.8, Figure 5.10). This low bootstrap value is 
reflective of the low number of gene isoforms, and indicates that the number of background 
cells in this experiment is close to the detection limit for individual cells. 
 
4.7 Single cell transcriptome variability 
Across all single cells detected in a background population experiments there was significant 
variation in gene expression. This was exemplified in the MAGED1 gene in single PC3 cells 
and PSA gene in single LNCaP cells. For example, only 3 out of 8 of the single PC3 cell in the 
29 HeLa background samples exhibited MAGED1 over-expression (Figure 3.8). MAGED1 was 
over-expressed in only 5 out of 8 single PC3 cell samples.  
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In LNCaP single cells in a 29 HeLa background only half the samples exhibited PSA over-
expression. PSA was more consistently expressed in single cells in isolation, with 7 out of 8 
single LNCaP cells showing PSA over-expression (Figure 3.10). MAGED1 had lower fold 
change expression in LNCaP single cells vis-à-vis HeLa cells than single PC3 cells. In both 
experiments with single PC3 and LNCaP cell detection in a HeLa background, there was no 
single gene that was consistently over-expressed across all samples that would indicate the 
presence of a single cell. 
 
The general PSA and MAGED1 gene expression patterns results are confirmed in the qPCR of 
bulk PC3 and LNCaP RNA (Figure 3.14). PSA is strongly expressed in LNCaP relative to PC3 
according to qPCR results, and has no expression in PC3 tissue. This is expected because PC3 
cells lack androgen receptors which are required for PSA expression (Kim and Coetzee, 
2004).  Increased MAGED1 expression in PC3 cells compared to LNCaP cells is also reflected 
in the qPCR of bulk samples (Figure 3.14B).  
 
Despite the variability of MAGED1 expression in single cells, MAGED1 could be a reliable 
candidate mRNA biomarker for low abundance prostate cancer cells in urine. This presents a 
subject for further study. Over-expression of MAGED1 mRNA in prostate cancer biopsy tissue 
relative to healthy prostate tissue has been characterised previously (Kumar et al., 2011). 
 
In the single PC3 cell detected in 199 LNCaP cell samples we observed 11 out of 23 gene 
isoforms with consistent over-expression indicating the presence of a single cell. However, in 
this experiment there were only three samples with a single PC3 cell. There were also more 
gene isoforms that distinguished PC3 cells from LNCaP cells (8261 gene isoforms, Figure 
3.12) than distinguished HeLa cells from either PC3 cells (6093 gene isoforms, Figure 3.8) or 
LNCaP cells (2262 gene isoforms, Figure 3.10). These factors may explain a more stable gene 
expression signature for single PC3 cells in an LNCaP background. 
 
The variation within the gene signature identifying a single cell in a background population is 
indicative of either technical or biological confounding factors. The systemic confounding 
effects are mitigated by the shrinkage effect of empirical Bayes (Appendix 5.3, Figures 5.5-B, 
5.6-B and 5.7-B). Systemic biological effects include cell cycle and cell size. Systemic technical 
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effects may originate during sample processing steps, such as the conditions of mRNA 
capture from a single cell. Variation in pipetting accuracy may also introduce systemic biases 
between sample conditions. 
 
Systemic biological (cell cycle) and technical (batch effects) variation are mitigated by 
empirical Bayes to a degree, however stochastic biological and technical variation will not be 
mitigated. Marinov et al. (2014) identify a significant combination of biological and technical 
stochastic noise in single cell gene expression. Biological stochasticity can be caused by 
stochasticity in alternative splicing machinery (Melamud and Moult, 2009).  
 
Transcriptional ‘bursting’ is another source of gene expression stochasticity (Kaufmann and 
van Oudenaarden, 2007). The concept of ‘bursting’ revolves around the observation that 
genes can spontaneously fluctuate between active and repressed states of expression (Bahar 
et al., 2015). Bacterial populations use this stochasticity of gene expression to maintain 
expression variation that improves adaptability in the face of pathogens (Moyed and 
Bertrand, 1983). Cancer tumour populations have also been suggested to use this ‘bet-
hedging’ strategy to adapt to chemotherapy and other existential threats (Sharma et al., 
2010). 
 
Wide variation in gene expression in single cell gene signatures is likely to be impacted by 
non-systematic biological and technical stochasticity because systemic effects have been 
mitigated. The stochastic nature of this variation makes it more difficult to statistically model 
and normalise.  
 
4.8 Conclusions and future directions 
We successfully removed a ‘hedge-hog’ concatenation artefact in our cDNA library. This was 
a pre-requisite for any further analysis of our single cell method. We achieved this by 
attaching a biotin molecule to the 5’ end of the TSO, which prevented concatenation. We 
further optimised the PCR protocol by selecting the best quality library produced by the 
Kapa HiFi HotStart DNA polymerase compared to the Kapa 2G Robust DNA polymerase. 
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Our high Pearson correlations within single cells of the same type illustrate that our method 
shows low technical variability within a single MiSeq Illumina sequencing run. According to 
the Pearson correlations, our method produced more reproducible results across single cells 
of the same type compared to Ramsköld et al., (2012). Our method was more sensitive than 
Ramsköld et al.’s method in terms of genes detected per read. However, technical replicates 
of single cells of the same type in separate sequencing runs would further validate these 
conclusions.  
 
We conducted trouble shooting  on a single cell/ultra-low input RNA method capable of high 
throughput gene expression analysis, producing an RNA-seq library for several thousand 
genes from a single prostate cancer cell. We successfully applied this method to detecting a 
single prostate cancer cell in HeLa and LNCaP background populations. We identified 
MAGED1 as a transcript that is significantly upregulated in half the PC3 single cells relative to 
a HeLa background and is also over-expressed in single LNCaP cells but not to the same level 
of statistical significance. This makes MAGED1 mRNA a candidate biomarker for low 
abundance prostate cancer cells in urine. 
 
We acknowledge the limitation of the experimental design for detecting rare prostate cancer  
cells in a micro-population with regards to an analogous clinical context. For example, HeLa 
cells are not a good model of  the heterogenous background of non-cancerous urinary cells. 
However, the experimental design might be applied to case-control analysis of ultra-low 
input RNA from patient urinary samples. Differential high throughput gene expression of 
urinary cell micro-populations between low risk patients and a patient cohort with increased 
risk of prostate cancer may discover RNA transcripts from intact rare pre-cancerous prostate 
cells. This may yield improvements in diagnostic specificity and sensitivity and evaluation of 
future risk. 
 
We observed significant variation between single cells detected in background populations 
which we attribute to non-systematic biological and technical confounding factors. The loess 
profile in the MA plots of differential expression analysis for single cells in background 
populations show that empirical Bayes and other normalisation measures removed systemic 
biases, such as cell cycle. This is supported by the absence of cell cycle genes in single cell 
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signatures. However, biological and technical stochastic effects remain, causing considerable 
variation between single cells. Accurately delineating biological and technical effects across 
single cell samples will require further analysis. 
 
While single cell analysis technologies will continue to push the boundaries of throughput, 
inexpensive and sensitive lower throughput well-based technologies will continue to remain 
useful for various ultra-low RNA input applications. For example, Clare et al. (2018) revealed 
new molecular characteristics that differentiate two neuronal sub-types by utilising the well 
based method developed by Day et al. (2018) and used in this thesis. Such well based single 
cell/ultra-low RNA input methods have shown better detection of low abundance transcripts 
compared to high throughput methods (Wang et al., 2019). Unlike high throughput 
microfluidic methods, well based methods are not restricted by cell size and shape. Finally, 
we have illustrated that well based methods dynamically accommodate a variety of 
experimental designs that would be impossible to implement in more rigid high throughput 





Figure 5.1 – Negative RNA controls for biotin TSO modification.   
Agilent 2100 Bioanalyser High Sensitivity DNA assay electropherogram traces of cDNA libraries for 
negative RNA controls in biotin negative (A) and biotin positive (B) TSO. DNA amount is measured in 
fluorescence units (FU). 
Figure 5.2 – Negative RNA controls for PCR polymerases.   
Agilent 2100 Bioanalyser High Sensitivity DNA assay electropherogram traces of cDNA libraries for 
negative RNA controls in libraries amplified by Kapa 2G Robust polymerase (A) and Kapa HiFi HotStart 
polymerase (B). DNA amount is measured in fluorescence units (FU). 
5. Appendix 























Figure 5.3 –  Single PC3 cells cluster independently of the single PC3 cell in 199 LNCaP 
cells in principal components analysis.   
Principal component analysis of samples shows that single PC3 cells in isolation clustered separately 
from single PC3 cells in 199 LNCaP cells in both the 23 gene isoforms (k = 2) and global transcript levels 
(k = 2) in the PCA/PAM.  
 









Figure 5.4 – Principal components analysis of Ramsköld et al. (2012) single cells. 
PCA/PAM clustering of single LNCaP and PC3 cells from Ramsköld et al. (2012). Data points are shown 
based on the first two principal components (PC1 and PC2) that capture the most variance and clustered 
according to the PAM algorithm (k = 2). Percentage values represent the degree to which each principal 
component accounts for variance. Ellipses assume a multivariate normal distribution with the confidence 







Figure 5.5 –  MA plots for PC3 cells vs HeLa cells.   
MA plots for 30 PC3 cells vs 30 HeLa cells (A) and single PC3 cell in 29 HeLa cells vs 30 
HeLa (B) that correspond to volcano plots A and B respectively in Figure 3.8. Average 
gene isoform log-expression is over all samples. The Loess smoothed curve (red line) is 
horizontal at y axis = 0, indicating the absence of systemic bias. 
 
 















































Figure 5.6 –  MA plots for LNCaP cells vs HeLa cells.   
MA plots for 30 LNCaP cells vs 30 HeLa cells (A) and single LNCaP cell in 29 HeLa cells vs 
30 HeLa (B) that correspond to volcano plots A and B respectively in Figure 3.10. 
Average gene isoform log-expression is over all samples. The Loess smoothed curve 



















































Figure 5.7 –  MA plots for LNCaP cells vs PC3 cells.   
MA plots for 30 PC3 cells vs 30 LNCaP cells (A) and a single PC3 cell in 199 LNCaP cells 
vs 200 LNCaP cells (B) that correspond to volcano plots A and B respectively in Figure 
3.12. Average gene isoform log-expression is over all samples. The Loess smoothed 

















































Figure 5.8 –  Gene expression view showing internal priming.   
Gene expression in MORF4L2 illustrates that RNA-seq reads are predominantly at the 3’ end of the mRNA 
sequence (green region). Reads also align with regions distal from the 3’ end, inluding in intronic regions. 
This is an indication of aberrant internal oligo-dT priming. 
 
 
































Tables 5.1 and 5.2  – Gene expression detection in single cells    
Statistics for the number of genes detected with the corresponding number of reads for Ramsköld et 




5.5 Single cell gene expression detection 
Genes detected for single cells 




Ramsköld et al., 








(%) Total reads Genes/reads 
LNCaP sample 1 23617 33175 71.18914846 20078740 0.001176219 
LNCaP sample 2 23867 33175 71.94272796 22814212 0.001046146 
LNCaP sample 3 23556 33175 71.00527506 28759799 0.00081906 
LNCaP sample 4 22294 33175 67.20120573 25071173 0.000889228 
PC3 sample 1 22885 33175 68.98266767 22711627 0.001007634 
PC3 sample 2 22789 33175 68.69329314 22776676 0.001000541 
PC3 sample 3 23435 33175 70.64054258 23182050 0.001010911 




Median =  
70.82290882 
Median =  
22998131 
Median =  
0.001004088 
 
    
      







(%) Total reads Genes/reads 
PC3 sample 1 5501 33175 0.165817634 23462 0.23446424 
PC3 sample 2 6127 33175 0.184687265 40235 0.152280353 
PC3 sample 3 5639 33175 0.169977393 25012 0.225451783 
PC3 sample 4 5618 33175 0.169344386 29074 0.193231066 
PC3 sample 5 5657 33175 0.17051997 28605 0.197762629 
PC3 sample 6 9167 33175 0.276322532 145815 0.062867332 
PC3 sample 7 6394 33175 0.192735494 39390 0.162325463 
PC3 sample 8 7301 33175 0.220075358 62305 0.117181607 
LNCaP sample 1 5816 33175 0.175312735 36310 0.16017626 
LNCaP sample 2 9707 33175 0.292599849 265790 0.036521314 
LNCaP sample 3 4853 33175 0.146284853 24102 0.201352585 
LNCaP sample 4 5635 33175 0.16985682 34599 0.162865979 
LNCaP sample 5 9621 33175 0.290007536 217128 0.044310269 
LNCaP sample 6 10816 33175 0.326028636 374678 0.028867454 
LNCaP sample 7 10875 33175 0.327807084 258300 0.042102207 
LNCaP sample 8 8861 33175 0.267098719 147729 0.059981453 
 
Median =  
6260.5  
Median =  
0.18871138 
Median =  
39812.5 
Median =  
0.156228307 
      
Table 5.1 – Gene expression in Ramsköld et al., (2012) single cells 
Table 5.2 – Gene expression in single cells under study 
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5.6 Cell cycle genes and single cell genes expressed in a background 
……population 
 
Cell cycle genes and up-regulated genes that distinguish a single cell in 
background populations 
Core 67 cell 
cycle genes 
Single PC3 
cell in HeLa 
Single LNCaP 
cell in HeLa 
Single PC3 cell in 
LNCaP 
ARHGAP11A ABI3BP AC006157.2 ABCD1 
BIRC5 AC073995.2 AC009475.2 AEN 
BRD8 AGPAT4 AR ALKBH8 
BUB1 AGXT2L2 BEX4 ARHGAP32 
BUB1B ALDH1A2 C20orf108 CLDN20 
BUB3 ANXA11 C8orf42 COCH 
CCNA2 ARHGAP29 CTD-2314B22.3 ENTPD7 
CCNB1 BCMO1 DDC EPB41L2 
CCNB2 C10orf55 DMXL1 FBXL13 
CCNE1 CERS6 FOLH1 HSPD1 
CCNE2 CHRM3 HOMER2 LAPTM4B 
CCNF CLDN14 KLK3 (PSA) PTPN21 
CDC20 CMTM7 LCP1 RP11-829H16.3 
CDC25B CNN3 MAOA SYNJ2 
CDC25C COL13A1 MIPOL1 TNIK 
CDC6 COL6A1 ODZ1 U52111.14 
CDCA3 CSMD2 PRAC VPS29 
CDCA8 DPP4 RPS4Y1 WFDC3 
CENPE DSC3 STEAP2  
CENPF DUSP6 TMPRSS2  
CHAF1A F2RL1 UTRN  
CKAP2 FAM43A ZBTB10  
CKS1B FAM84B ZIM2  
CKS2 FER1L6   
DTL FOSL1   
E2F1 FOXP1   
ESPL1 G0S2   
EXO1 GNG2   
FAM64A GPR110   
GPR126 HAS3   
GPSM2 HIPK2   
GTSE1 HMGA2   
H2AFX HOXB13   
HMGB2 HTR1E   
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Table 5.3 – Genes over-expressed in single cells relative to a background population 
List of genes from the ‘core 67’ cell cycle genes (Dominguez et al., 2016) alongside genes that comprise 
the gene isoforms which distinguish single PC3 and LNCaP cells in a HeLa or LNCaP background (Figures 

















Core 67 PC3 in HeLa   
HMGB3 KIF5C   
HMMR KRT19   
HSPB8 LPAR1   
KIF11 MAGED1   
KIF22 ME1   
KIF23 NDST3   
KIF2C NEFL   
KPNA2 NES   
LBR NFIX   
MCM2 NRP1   
MCM6 NTNG1   
MKI67 OAT   
NDE1 PHLDA1   
NEK2 PKP1   
NUSAP1 PLAU   
PASK PRAC   
PCNA PRSS3   
PLK1 PSD3   








RFC4 RP11-463J7.2  
 
SFPQ RP11-65F13.2  
SLBP RP11-66B24.4  
SPAG5 SATB1  
TACC3 SCOC   
TOP2A SHISA3  
TPX2 SPATS2L   
TROAP SPINT2   
TTK SULF2   
UBE2C SYT1   
UBE2S TMEM45B   
UNG TRIM58   
 TSPAN5   
 UCHL1   
 ZNF503   
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Figure 5.9 –  Cumulative distribution plot for all single cells.   
This plot depicts the distribution profiles of all gene expression values across all single cells (Ramsköld et 
al. and ours) after scaling the read counts of all samples to the sample with the highest overall read count. 





















Figure 5.10 –  Dendrogram for detecting a single PC3 cell in 199 LNCaP cells.   
This plot depicts the statistical separation between 200 LNCaP cells, a single PC3 cell in 199 LNCaP cells 
and single PC3 cells alone. Node numbers (‘edge #’, in gray), bootstrap values (‘bp’, in green) and 
corresponding approximately unbiased P values (‘au’, in red) are shown for each node. The complete 
linkage method was used for hierarchical clustering. The uncentered correlation function was used for the 
distance measure. Bootstrap values were generated from 10,000 bootstrap replications. 
 
 






5.9 Reagent preparation 
5.8.1 Cryopreservation 
 
The freezing medium for cryopreservation of all cell cultures consisted of 95% complete 
growth medium with 5% DMSO. 
5.8.2 Trypsin preparation 
 




5.8.2 PBS preparation 
 
PBS was prepared by adding 1 PBS tablet per 100 mL in mQ H2O, then autoclaved for 
sterilization 
5.10 R packages and code 
5.10.1 Heatmap code 
 
#Read in data 
>library(gplots) 
>data<-read.csv('gene_expression_file_from_seq_monk.csv') 
#Remove genes without expression across all samples in file 
>data_mat<-data[apply(data[,2:ncol(data)], 1, sum)>0,] 
#Normalise data by the standard deviation 
>data_norm<-t(apply(data_mat2, 1, function(x) (x-mean(x))/sd(x))) 
#Plot heatmap 
>heatmap.2(data_norm, distfun = function(x) as.dist(1-cor(t(x), method = c("spearman"))), 
Rowv = T, dendrogram='column', col =colorRampPalette(c("green","white","red"))(100), 
scale='row', trace='none', margins=c(2,4), ylab='Genes', cex.lab=0.75, cexCol=0.8, srtCol=20, 
lwid=c(1,3.5)) 
5.10.2 Volcano plot code 
 
#Read in data 
>library(limma) 
>data<-read.csv("gene_expression_file_from_seq_monk.csv") 
#Select only gene expression data from file generated by SeqMonk 
>x<-data[,grep("Mean", names(dat))] 









#Produce volcano plot 
>with(tt, plot(logFC, -log(adj.P.Val),pch=9,cex=0.3,col="black", xlab="Log2 Fold Change", 
ylab="-log Adjusted P value", main="title", ylim=c(0,8), xlim=c(-6,6))) 
>with(subset(tt, adj.P.Val<.05 & logFC>1), points(logFC, -log(adj.P.Val), pch=9,cex=0.3, 
col="red")) 




#Produce MA plot 
>plotMA(fit, main='title’, ylab='Log2 Fold Change', xlab='Average Expression') 
>abline(h=0,col='red',lty=1) 
5.10.3 Principal component analysis code 
 





#Remove genes with zero expression across all samples in file 
>data_mat<-data[apply(data[,2:ncol(data)], 1, sum)>0,] 
#Convert data to log2 scale and normalize by the standard deviation 
>pca = apply(data_mat,2,function(x){ 
  x[x==0] = 1 
  x 
  l = log2(x) 
  (l - mean(l))/sd(l) 
 104 
}) 
#Generate first two principal components 
>pc  = prcomp(t(pca)) 
>scores <- data.frame(pc$x[,1:2]) 
#Clustering by partitioning around the medoids 
>autoplot(pam(scores[-3],*input k-value, e.g. 2*), frame = FALSE, frame.type = 'norm') 
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